Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : . . . . 2 . .] 221
batch____ bits E-value N 100.0% 1:221 MLDLFKAIGLGLVVLLPLANPLTTVALFLGLAGNMNSAERNRQSLMASVYVFAIMMVAYYAGQLVMDTFGISIPGLRIAGGLIVAFIGFRMLFPQQKAIDSPEAKSKSEELEDEPSANIAFVPLAMPSTAGPGTIAMIISSASTVRQSSTFADWVLMVAPPLIFFLVAVILWGSLRSSGAIMRLVGKGGIEAISRLMGFLLVCMGVQFIINGILEIIKTYH
1 UniRef50_A3P530 MarC family integral membra... 169 7e-41 1 27.4% 4:218 195:405 ---LISEILFGFTGLMGIINPFGIAFLFLERTESLTEAQRAALARKVAINAFIVLLAAFFVGTPILHFFGISLEALRIGGGLAVAVAGWQMLNEPDVPT---GGDTAAQPVEPRNAMARAFFPLTIPLTTGPGSIATAIALNANRTHKLSEFVLSSIVSVAVS-ALAALVIWQTYSRAAFLARYLGTEGTKVAMRVSAFLLLCVGVQIMLTGFSEFLR---
2 UniRef50_A8AGR9 UPF0056 inner membrane prot... 165 1e-39 1 92.8% 1:221 1:221 MMDLFKAIGLGLVVLLPLANPLTTVALFLGLAGNMNSAERNRQSLMASVYVFAIMMVAYYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQKAHESPEAKSKSEELEDEPSANIAFVPLAMPSTAGPGTIAMIISSASTVRHGVDFPGWVILVAPPLIFLAVSVILWGSLRSSGAIMRLVGKGGIEAISRLMGFLLVCMGVQFIINGVLEIIKTYH
3 UniRef50_C6X9P4 Multiple antibiotic resista... 165 1e-39 1 26.9% 2:220 1:209 -MSEWAYLFKTGIALFAIVNPVGSVPIFISATDGWSPKDRARTAKTVGLTVFVVLMTSAFLGNGILDFFSISIPSFQVGGGILVMLIAISMMHGKQSHARQ----TPEEAQAVAEREVIAIVPLSIPLLAGPGAISSMIITAQKHSGFW------GHVSLIVPVAAVCLLIWLTLRLSSAIAHKLGTLGINIVTRLMGLILAAMAVEFIAQGISGLFPGL-
4 UniRef50_D1CJ06 Multiple antibiotic resista... 163 4e-39 1 23.5% 5:221 1:208 ----MNFFLKALVALFTIVDPIGMAPIVVGLTAHLSPAVRRRVVTRATLIATGVVAVFALFGKPLLEFLGITPEAFSIAGGALLFLVSIDMLFGRESGAR----ETGREAREARTREDISVFPLAIPLIAGPGTITTVILLMDSAQGHASR-----QLAVAAAVAIVMFCTWVSMSLAFPIQKRMGTTGTLVLSRVLGMLLAAIAIQYILNGLSSFAESLR
5 UniRef50_A3IQE6 Multiple antibiotic resista... 162 9e-39 1 27.6% 5:221 3:209 ----FSEYINSFITLLAISNPIGNLPIYLGLTADKTKKQRQQTIKTASIAFAIILIVSCFMGEVILSAFGISIASFRVAGGFLIFIFGFHMLQAKTSDIHH----TSEENQDAQTADSIAIVPLALPLLAGPGTISSVIVLAHKTQ------SLVEKLGLSIVIIILAILIFISYSFAHVIGNFLGKTGMNIVTRLMGLITMAMAVQFMADGLEVLFPGWK
6 UniRef50_A8HXT9 Multiple antibiotic resista... 161 1e-38 1 25.9% 1:220 1:223 MSQFINIFVAVFAALFPIVNPLGGAPIFYEMTRACAPQVRASLAMKVAIYGFILLVVSLVAGSRILTFFGISLPVLRVAGGLVVTFVGWNILHQGDASAEKAPDATATRDVDVLRVEQQAFYPLTMPLTMGPGSIATAIALGSQgpADGYGHMIIEAMGALSGIAAVSASVYFAYRYASDIERFLGPNGTNVLVRLFAFILLCIGMQIMWLGIRDLVASL-
7 UniRef50_B6IWJ1 MarC integral membrane fami... 159 5e-38 1 26.5% 2:220 1:209 -MEPWSEYSRFIVALFAMLTPFAAIPIFLGLTEGRTDAERNRTAASAALTVFSVLAGSAFLGNAVLAVVGTSLDSFRVGGGIVLLLIALSMLNATVSAVKQ----TPTEADEAASRHAIGVVPLGLPLLAGPGSISAVII------ETQRGSGWEHTAIIVGSITLVCLFIWLSLRLAVPIGRMMGRTGLNIMNRLFGLLLAAVAVEIISTGLRNLFPGW-
8 UniRef50_C1D8X8 Probable multiple antibioti... 159 6e-38 1 29.9% 7:220 2:205 ------EVFKIFIALLVLVNPIGAIPIFISLTPNSTAEERQRIALTTSKAVAIVTVTFALLGETILKFLNISVGSFQVGGGILMMLIAIAMMNAKQTPTKT----TRQEQEEAEFKTNIAVVPLAIPLMTGPGTMSTIIIYASTSH------DWIELVMLLLACGLIAVTCYVALRAATPISRMLGQTGINIVNRVMGMVLAAVSVEVIVNGLYRLFPML-
9 UniRef50_Q13TQ7 Multiple antibiotic resista... 158 1e-37 1 31.3% 8:221 3:206 -------ILKSFISLLALINPVGAIPFFMSLTAHQSDAERRRTIRIAAISVFCVIAVTTLLGQQIIAFFGISVGSLEVGGGIIMLLMAINMLNAQIGNSRS----TPEERHEAEQKDNIAVVPLAIPLLTGPGAISTTIIYAAGSAHWYDRISLVAIGAVLAAI------CFFSLRLAEPIARWVGRTGINIGTRLMGLMLSALAVEFIVDGLKALLPNLK
10 UniRef50_D0KYA2 Multiple antibiotic resista... 158 2e-37 1 32.6% 1:215 1:209 MPDLMHHALTAFMAFLAMMNPVANAVIFLGLTADMGLATTRHVAWRAVRTAFFIVLTFALFGPLVFSLFGITLPALRVAGGVLIALVGFRMLHGENSRVSHPKQIPSESGSEVDSSqdIAITPLAIPVLAGPGTIATAMSYSPSGH-------WMQTGATILMFTLICALTFYAFVFSERILARIGRGGVAVITRLMGLILAVIGVQMLLDGLHQ------
11 UniRef50_C1D7D3 Probable multiple antibioti... 158 2e-37 1 25.8% 8:220 11:223 -------FLFALAALLPIINPPGLIPIFLSLTSRNTREQRQFLARRIAIYGFVLLAGSMFIGSYLLSFFGVSLPVVQLGGGLLLTFTAWRMLNDTP--AEHSTHAPEPEHIDQAQLKQRAFYPLGFPLTVGPGSVSVSITIGATFFHSNHNFVQLAlvASLLAVAVVCYLIYFCYLHAETMLHHLGPTGAVVFLRLSAFILVCLGMQIMWNGISELISGW-
12 UniRef50_O32244 UPF0056 membrane protein yv... 156 6e-37 1 26.3% 4:220 2:209 ---MFSFIVHVFISLFAVSNPIGNVPIFLTLTEGYTAAERKAIARKAAILSFFILAAFLVFGHLIFKLFDINIHALRVAGGIFIFGIAYNLLNAKES---HVQSLHHDEHKESKEKADISVTPLSIPIIAGPGTIATVMSLSAGHSGIGH------YAAVMIGIAAVIALTFLFFHYSAFISSKLGKTEMNVITRLMGLILAVVAVGMIGAGLKGMFPVL-
13 UniRef50_A0NQU3 Putative uncharacterized pr... 155 9e-37 1 25.5% 4:219 1:211 ---MLDYYINAFATLFVTIDPVGLAPMFLAITAGMSKHDRRKVAVRATITAAGILLVFYASGQTVLNVLGISVSAFRVAGGILLFLIAIEMIFGKRQARKTETAEKAMeeAHHGTINELAIFPLAIPLISGPAAISAIILLSSQAPDT------LAYAGLGGVIAIILLSCMGAFLLADKIERLLGETAQLVITRLLGVLLAALSVQFVADGILAFIRT--
14 UniRef50_Q7NUG9 Probable multiple antibioti... 154 1e-36 1 23.2% 1:220 4:224 LSTFITKFLFVMAALLPIMNPPGLVPIFISMTARNTPQQRRYLARRIAIYCALLLVGSMFVGGYVLSFFGVSLPVVQMSGGLLITFAAWRMLNDTPAESSQPSAEQARVDSQAELKQ-RAFYPLTFPLTVGPGSVSVAITIGATLTGSGKGLvvISPIAGLSAVLVGSTLVYLCYANADKLLRYLGQTGSVVFLRLSAFILLCLGVQIMWDGFGELASQW-
15 UniRef50_A0B911 Multiple antibiotic resista... 154 2e-36 1 23.6% 4:219 22:226 ---YLQYFVYVFTSLFIIVSPIEATMVFVSLTQDASPAERDRICVRTTLVAFSIAMVFALAGDMILRFFGITVDSLRVAGGILLFLVAIDMLRAKP-----HKKVTQAEIEDATTREDISIFPLAIPLLTGPGTITTVIVHMGASNT------LPEKMIVLLAICLTFGATYAILKSAEHIHDILGVTGIMVFTRILGLILGAIAVDFVSVGAWNIYIS--
16 UniRef50_O66819 UPF0056 membrane protein aq... 153 3e-36 1 26.1% 1:218 6:213 MEEFGVLFVKAFLSLLAIMNPFSSVPVVISLMNEYSKEEIRVIALKASVYAFFILTFFLISGDLLFRFMGITLPAFKVGGGILLFLIALNLVQGEVT----KEKGKAHEIEAALRRDNIALIPLAMPLLAGPGSITTVLVL------RGYLNTLEGKVALFCAIFLSSFTAFVVYSLSTFFYRVLGRTGINLITRISGILLLAISVQFVVDGLKNLLK---
17 UniRef50_Q2IJJ0 Multiple antibiotic resista... 153 4e-36 1 23.4% 1:218 1:206 MKPLLDYGLLVFVSMFTMMGPVGVLPPFVSMTSGLSGDEARRVARRATITALCVLLVFALGGQLVFRFFNISVNSLRVVGGIILLLVGYEMLQARPSRTKH------DEPAPEGYAEDIAITPLGIPVIAGPGAITTVIILMSEAH------DLARKAVLLVVLLGLHVLTYAMLVSAKPLLAFLGPSGNKVLVRIMGLIVMVIAVEFFFAGLKPIVR---
18 UniRef50_B4U7Z6 Multiple antibiotic resista... 153 4e-36 1 29.4% 3:220 8:215 --DIIYFIIKFSISIFAILNPFGALPVLVSLTKGYTKEDRSYVIRTSSIYAGLTLIFFVLFGDLLFEIFGIGLGAFQIGGGIILSFVSINMIFGQP----HRERASNQELEEAEQKENIAIVPIAIPLLAGPGAISTVITIASSYR------SVFYHVLLILSILVACIGVFLVFKSVDKIVKILGKIGINILSRLMGILLMSLAMQFIIKGIQLAFPTL-
19 UniRef50_Q0C4W2 Membrane protein, MarC fami... 153 4e-36 1 20.8% 2:217 3:213 -PELISLFTAAFVTFFVLIDAPGVAPIFATLTAKGSPAYRRKMAYKSVFVATIIMLLFAFGGAWLLDAMHISIDAFRAAGGVLLFLIALDMVFEKRTERREQRADEveEHRNDPEPEDVSVFPMGIPMIAGPGSIATAMFYMTEAE------SIAHQGVVLAAIGANLLITLIIFLLATPIVRLMGASVAGALTRILGVILAALSAQLILDGIRGAF----
20 UniRef50_Q1IWE7 Multiple antibiotic resista... 152 6e-36 1 30.9% 3:219 5:212 --ELSSISLQTFLTMLVVMDPIGLAPIFIGLAGNRPSFERRRMALRASVVAGVIILCFGLFGRGLLDHLGISLSAFRVAGGILLFLIALDMVFARPSGSK----ETPEEGQEAQERQDISVFPLAIPLIAGPGTLASIMILAGDAHGNP-----ALLAAVFVVTFLVLLLCYLALRLSGQIARVIGVTGVHVVTRVLGVLLGALAVQYVADGALEFLRG--
21 UniRef50_C1CXZ5 Putative multiple antibioti... 152 8e-36 1 29.0% 3:219 6:213 --QFLTTINKTFLTMLVVMDPIGLAPIFIGLASNRPRFERQRVAFKATLVAGIIILMFGLFGRDLLKHLGISLSAFRIAGGVLLFMIALDMVFARPSGSK----ETPEEEQEAHERQDISVFPLAIPLIAGPGTLASIMILAGDAHGEP-----LLLGGVFSVTFLVLLLCYLALRLSGQIARVIGLTGVHVVTRVLGVLLGALAVQYIADGTLELLRG--
22 UniRef50_C1DAG1 Probable multiple antibioti... 152 8e-36 1 26.7% 4:220 8:222 ---FASKVLFVIAALFPILNPPGHAPLFLSLTVHNTPEERAILARKVGIYSFMLLLPSMFIGSYVLRIFDITLPFVQVGGGILVAIAAWEMLADKHGP--SPEEQAEPHQLDQNALSQRAFYPITFPITVGPGSITVAITVGASMQGKGLESFTLLPLASFVAVSLIAYSLYWSYRYADRLLRLLGPNGTMVFLRLSAFILMCLGVQIFWEGLTQLILQF-
23 UniRef50_C5U4I6 Multiple antibiotic resista... 152 1e-35 1 23.7% 4:218 2:205 ---DIQYFIISFTSIFSILNPIGAVPIFISLTESYPEKERILVAKKTVIYAFSILLAFAVFGEYILKFFGISIEAFKIGGGILLLLIALDMVRGKQESKIHKR-----EIKEADEVDEIALMPLATPLLAGPGSITAVMVAMAEAPSFEDR------IFVILAILISIFITYLTFVFSERIIDKLGRLGTRILTRLMGLILTAIAVQMILTGYLGVVR---
24 UniRef50_A7JXE2 Multiple antibiotic resista... 151 1e-35 1 26.9% 1:219 1:210 MKELIVHTVTVFMGFFAIMNPIANIPIFLSLTADEDKETVRSMALRSVFIAFVIIAIFSIAGKLIFDLFGITLYALRITGGILVFLIGFNMLQGDSTHQKTKEKAYSPAQQQAA--LSIAVSPLAMPILAGPGTIATAMNFAT-------AGGFDQTIITIVSFAVLCVITYILFLFGDKLVKAVGPSALNVVTKMMGLILAVIGTQMFIDGAGEAYKT--
25 UniRef50_D1JHZ5 Conserved hypothetical memb... 151 1e-35 1 25.6% 2:220 4:213 -TTLVGFLCTCLGGYFAIMNPIANTPVFISLTQGDDAATKKAVARNSILFAFVLIAFLSFAGNFIFKLFGITQPALQITGGIIIFMIGYHMLQGSGSKAHTPSD--DDIESSRKARLNVAISPLGIPILAGPGTIAVAMGYAAGFE-------LIHVILSLLAFGVICGITYLCFRGSEEIVEHLGQNGLNVITRLMGLCLAAIGTGMVLSGLGADIHTF-
26 UniRef50_B5EJL1 Multiple antibiotic resista... 151 2e-35 1 25.0% 5:220 7:212 ----LHSALQTLIALLAILNPVGAIPIFIALTSDEDPQQRLATAKLASRAVAVVLLTSAFLGEYILQFFGISIAAFQVAGGMVLMLLAFNMLQAKSSRYRH----TPEEAAEGMQKEAVAVVPLAIPLLAGPGTMVTVII------AHHKNASWLASGLLIIDILVIAGVAYAALRLAEPLSRRLGVTGINISTRIFGLVLAAIAVTFIANGLAALFPGL-
27 UniRef50_Q1Q2V4 Putative uncharacterized pr... 151 2e-35 1 25.6% 2:220 1:209 -MEHWTEYTRFLTALMVILDPFAAIPIFLSLTQGYSQSQRARVVLVTIITVALVLISSAISGESLLKTFGTSLASFRVGGGIVLFIMALAMLRAQADKVKTSP----TEEAAAENKATIAVVPLAIPLLAGPGSISTVIIEMHRSSATYHGA------LVILCILITCILLWIVLRLASPIGRALGPIGRNILNRLFGLILTAIAIEIIANGLRELFPSL-
28 UniRef50_D1BXK0 Multiple antibiotic resista... 151 2e-35 1 24.7% 4:218 6:209 ---DVALFIEVFVTLFVIMDPPGSVPVFLALTSRMTPKQRNRAARQAILVAFGVIVVFAAFGQQLLQYMGITLPALQASGGLLLLFVAMELLTGKM----------EEPEPAKGGAVNVALVPLGTPLLAGPGAIVATMVFV-QRRLEADEPVLAHWAAIVLAVIAVHLCVYLAMRFANTIQRILKDSGVTLVTRIAGLLLAAIAVQMIATAVTEFVR---
29 UniRef50_B2JWZ3 Multiple antibiotic resista... 149 6e-35 1 26.7% 3:219 18:232 --QFGETVLLVVAGLFPVINPPAAGFIVLSLVPHATEKERAFLARSISINSLVILLVSLSIGAYVLSFFGISLPALRVAGGLVIAFAGWNLLHEQADTDREPDQAPAHDVSREVSLRSKAFYPLTLPITVGPGSIAVAVALGTGRPRGG--IAWIHLAGVLVALALLWASIYLCVRFAANLEKLLGPVGTEIAMRLFAFVLFCIGVQILWLGVDDLLES--
30 UniRef50_B2IEA6 Multiple antibiotic resista... 149 6e-35 1 25.6% 4:218 1:208 ---MFPYLLQTFTTLFVVVDPLAMAPLFIAVTAGLTPVERRIVGRRACLSALFILLGFALLGETLLTVTGISLQAFRIAGGILLFWIAFEMVFHKRSDRKSAEVA-RTERPDETEILGLAVFPIAMPLIAGPGAIAAVIVATTHAPNTTAF------FGVIVLIIAIMAMTFVVLQIADRIDAFMGPTGRAVISRLLGVLLSALAVQIAIDGVHGLIP---
31 UniRef50_A6KWY6 MarC family integral membra... 149 9e-35 1 27.2% 1:217 1:205 MDTLLPFALLCFTSFFTLTNPLGTMPVFLTMTKGMDDEERRHIVKRATIISFITLLAFTFSGQFLFKFFGISTNGFRIAAGFIILKIGYDMLQARFTNTKLKDEEIKTYA------NDISITPLSIPMLCGPGAIANGIMLMDDANT------WTMKGILIGIIGLIYFITYLILRASTRLVSILGETGNNVMMRLMGLILMVIAVECFVSGFRPIL----
32 UniRef50_Q03GN0 Multiple antibiotic transpo... 147 2e-34 1 25.3% 2:218 1:206 -MNLVQAFLLSFTAFFAIMNPFANLPMFVSLTADNNRKEVDAIARLAFIVATVIVALFALLGNYIFSIFGINLSALRIMGGIILGLIGYHMIQGNVSPIQHDPKQSVKDSINSNNT-DVAISPLAMPVLAGPGTIATTMNLSSSTNP----------FIVISAFVVLSVITYFIFIYGEQIMAKLGNNIMNVITKLMGLILATIGVRMLIMGVQVAFH---
33 UniRef50_A9A830 Multiple antibiotic resista... 147 2e-34 1 24.3% 4:217 2:212 ---DVQFIILAFTSLFSILNPFGVIPTYLVLTSQYSKVEKIKIIRKSMLAAFTILMMFALLGNQIIGFFGISIPAIKITGGVLLFLIALDMIQGNTSKVEKSPKLEShhSEEIEEMNEIAIVPLTVPLLTGPGSISAVIAMMAQTN------DFDGKISVIIAISLCIIISYFVLKFSKDLERILGKIGFKVLTKMMGLVLTAISIQMALDGILMVF----
34 UniRef50_C8WCE4 Multiple antibiotic resista... 147 2e-34 1 23.3% 4:218 1:207 ---MISLFISTCISLFVVIDVPGCAPIFASLTKNATSTEQRTMAIRAVLVSSGILVFFGFLGESFLRAVGIGLAAFRIAGGILVLLTAIEMVFEKRTQKREDRARQVKKIPE--EAEDISVFPMAIPMIAGPGSIATIMLLISKTEN------WEQRITVFGALGAIQIMMVISLILAGPIMRVLGRRAEAMITRVLGLILAALAIQFILDGLKEFFH---
35 UniRef50_B4ETK1 Multiple antibiotic resista... 147 2e-34 1 61.7% 25:220 28:222 ------------------------VALWLGLSGNMTKEQRNQQSFMACVYIFIIMTIAFYAGRVIMTTFGISIPGLRIAGGMIVAFIGFSMLFPHTPNVDDPLSEEKNPHRNPQAP-NIAFVPLAMPSTAGPGTIAMIISTAASIPSRTDIAQWVLYVAPITTFFLISLIVWLSLRGSTGIMRYLGHSGIDAISRVMGFLLICMGVQFMINGVLEIIADL-
36 UniRef50_Q58382 UPF0056 membrane protein MJ... 147 2e-34 1 24.8% 2:219 17:224 -MDILNFYIYGFVSLFITIDPIGLIPIVHSLTYPYPKEQRIRIIKKAIISSTVVLLLFALFGNYIFGYFGITIDAFRVAGGILLFKIAWDMLHAEIPKTKHKP----DERLDLEDIDSIVYVPLAIPLISGPGAITTTMILISKTQ------SILEKGVVVLSILSAMLVSGIILSLTDFIIRRVNIYGINAFVRIMGLLLVAISVQIIFTGIVGLYNS--
37 UniRef50_B5JMP6 Putative uncharacterized pr... 147 2e-34 1 22.2% 1:216 1:206 MGSSLEFLLLSTVSIFTIVNPFSAVPAFLAITPGESVVERRRSARLACLIAVCLLILTAVLGEFIFSLLGITLPALQIAGGVLLFSIGFEMVRAPDAPKR----LNETESDLAKEKEDISVTPLAVPLLCGPGSVSTVIILQGQTTSMMESS------MLLVSIVVVFVACYLILSASAKGGEWLNPILMRILRRVMGLLFAVIAVQFVVNGVGDL-----
38 UniRef50_C1D6U8 Multiple drug resistance pr... 147 2e-34 1 30.9% 4:220 7:214 ---FSQYFLGAMLSFVVITNPLSKIPMFLSLTPGQTPVQKNRVAFTACAYAGAIMVVSLIGGNLVLSMFGISYGALRVAGGLVVAGVGYKMLYQAHDSTSHAHRES----------VDVSFFPLAMPGISGPGTIAVVIGFSTeaEITDWRWKIAAILITLGAIGGTMLVVWLSLKLSAKIAERIGPSALDVLTRLMGFLLICIGVQFVGSGIRTFYSTL-
39 UniRef50_B9XPN0 Multiple antibiotic resista... 147 2e-34 1 22.3% 2:216 1:205 -MSLFEYTLLAGSSLFVIVDPVATVPAFIAMTPHDTPEQRIKTARLACFVMAGVLLSFAAAGRVIFKLMGITMPAFQIAASIVLLLVALDMLRAQ----RSRVQETHEETEAGAEKADIAVTPLAIPMLAGPGAISTAILLQNQAKTAAQHA------AVYVCILGVSFASYLILKVSARGAKWLNPIAMNVAIRIMGLLLAAVAIQFGLNAFKTL-----
40 UniRef50_B6JA04 Putative membrane protein n... 147 3e-34 1 28.0% 3:220 6:218 --EIVNAFLLVYAALFPVINPVGGAPIFLRLTNRTPKARLPSLARGVAINSFVLLLCSLFIGSHVLVFFGITLPVLRIAGGLVVAALGWRLLHQGDDLEGRDQPAPREKEVD-------AFYPLTMPLTVGPGSISVAITLGSQRPSSalAQLAALGGGAATGLAAIAATIYVCYRFAGNIVTVLGERGTNVMMRLSAFLLFCIGIQIIWGGLRTLLPQL-
41 UniRef50_Q1GI30 Multiple antibiotic resista... 147 3e-34 1 27.9% 2:216 1:203 -MIDTAFLITSFVTLFVIIDPIGLMPVFLALTQGMTSKQRRAIAIRASITGIGILAVFALFGESVLGFIGISMPAFRVAGGILLFLTALDMLFERRTARRQHQG------DEIAPEDDPSVFPMAIPLIAGPGSIATVILLTGQHPGIEGFASVMAIVVAVIALMLGM------FSISGALERLLGPVGINVATRLLGMLLAALSVQFVLDGLSAF-----
42 UniRef50_Q7NGH4 Gll3195 protein n=1 Tax=Glo... 147 3e-34 1 27.5% 1:218 1:208 MRPMWESVLgtFLALLPVTDPLGAVPIFYSLTSSGSDSYRRRQARLTTIHVLWLLAGFLLVGKVVLEFFGISFAVLRIAGGLLIAQTGWEMVN--------SHRHEGDTALAANTSGDIAFAPMAMPLVSGPGAIGVVIGLSSKASG------WPDYFGSLVGIALVAGVLYLCLMLGEPLLKRLGRAGTRALNQILGFLILAIALQFMVDGLRELLR---
43 UniRef50_A8GDQ2 Multiple antibiotic resista... 147 3e-34 1 80.0% 1:220 4:224 ILQLFQAIGLGLVLLLPLANPLTTVALLLGLSGNMTREERNQQSLMASVYVFFIMTVAFYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQSADEAPEVESKSKELRKKTSANIAFVPLAMPSTAGPGTIAMIISSASSveNTLGFAHWVLLVAPVAIFLSVALILWACLRSSGAIMRLVGQSGIEAISRLMGFLLVCMGVQFIINGILEIISTY-
44 UniRef50_B5I9R7 Multiple antibiotic resista... 146 4e-34 1 22.4% 4:217 2:202 ---DVNTFLHIFIPLFAVIDPFAALPLYMSLTTGLSETQKRKIVKEASLTAIVLLIFFAFLGIYILDFMGISIEALMIAGGLLMLLVSLEMVKEGDKPRSTKKKVALHEET-----GDIGIVPLGTPMLAGPGAISLVIILMSKYPTEWDSIVISIVGIIIL--------TALIFLGSNLISKIMGEKGSRAFTRVMGLLVAAFAVQYILDGVAQYF----
45 UniRef50_B9JF99 Multiple antibiotic resista... 146 4e-34 1 27.3% 2:217 1:207 -MASADTLINAFTTLLVTVDPPGLAPLFIGLTAGMNRAERKQVALRGSLIAFFILAAFALFGASVLGILGISIGAFRIAGGLLLFWIAFEMVFEKRQDRKEK---TTEVAITKDHIHNIAVFPLALPLIAGPGAISATILLAGSLQTTFDRAQ------LIGVIAVNLGLVFAALAISDRLDRMLGATGRAILTRLLGVILAALAAQFVVDGVRSAL----
46 UniRef50_B4WGQ9 Putative uncharacterized pr... 146 4e-34 1 25.9% 1:220 3:220 IRDFADFILGSIAALFPVMDPIGSVPVFLVLTAGVPQSLRHSYARRIALNVIFLLISFLLVGGGILRFFGISLEVVRIAGGIVVFHAAWNTMNA---ESKMSELENQDAAQKAGEHKDISFMPMTIPLLAGPGSIAVVLGLAAEarGAGTVETAQNLLAVVIAIGLIGLIIYVALRSSSLLLKWLGAGGIQALSRLLGLFVMAIGVQLILSGLGDWIESL-
47 UniRef50_B9NN29 Putative uncharacterized pr... 146 4e-34 1 23.3% 6:220 4:209 -----TLAVGFFGALFAIMNPVTNLPVFLSVTQDLSVADQRKVAIKTATYCLILGTAFAAVGSQALSLFGISVNDLRVAGGLVVLMIGFNMLSGNESTSHHGTDGEKESYPAA---DTVAFYPLAFPILVGPGTITTLILYAHHVKTT------VDIFVYAGVFLAILALLLITFWNAAWLAKRLSANARVIMSRFMGMILAAIAISMIADGLKVLLPGL-
48 UniRef50_D2RH21 Multiple antibiotic resista... 146 5e-34 1 20.8% 2:213 4:204 -VDYISYFVTAFTTIFVIVDPPGNIPFFIALTERFSEKERDRVSKKSTLIACALLIIIALSGDILLKFFHISIESLKVAGGILLFVIAIDILLGGARKEFYAKRGLKH-----IDVDSLAVFPIALPLYTGPGAITATIVLSAEA------SDIPSKILLIASIALVYIIVRLTHVYSEVVIKVLGKSGSDIVARVMAIFLAAIGVEYVFSGL--------
49 UniRef50_B5ZPR0 Multiple antibiotic resista... 146 5e-34 1 27.3% 2:217 1:207 -MASADQLINAFTTLIVTIDPPGLAPIFLGLTTGMSRAQRTQVALRGSTIAFIILAVFALFGASVLGVLGISIGAFRIAGGLLLFWIAFEMVFERRQERKEKATEAA---VTKDHIENIAVFPLALPLIAGPGAISATILLAGTLPTSVEKAQF------IAVIAANLLLTFLMLLIADRLDRFLGVTGRAILTRLLGVILAALAVQFVVDGAKAAL----
50 UniRef50_A8FYJ7 Multiple antibiotic resista... 146 6e-34 1 28.4% 1:218 1:217 MDGLWLHLGTVFMGFFAIMNPIANVPIFLGLTSEEDEQTTKAIAFRALLLAFIIITVFALMGQFIFTLFGISLSAFRITGGFLVFLIGFHMLQGNNSSVHHPDSAQVEESKAkeAALSIAVSPLALPILAGPGTIATAMSFSA-------VGGVAEMLITIGTFGALCVVTYLFFIFGGRLVNYLGSAALGAITRMMGLILAVIGTQMAIEGIKGAFA---
51 UniRef50_B0C1W1 Multiple antibiotic resista... 146 6e-34 1 24.7% 2:220 1:215 -MFDLPEYLKLVAGLASIVNPVGVIPIFLSLTEGQGSSQRRLIAFQSSIALSIVLLVALVAGEAILSFFSISLPSFRVAGGLLILLTALSMLRAETIESRQLTETGTVDPNEPPTLPdvAVVPIAIPLLGGPGAISTVIVYAHTQE------SIEHTILVGLAILSVSVIALVGLLIAPLMDTVMGKTGMNVISRVMGLIITAISIEFIADGVKELLPGL-
52 UniRef50_A7HDJ2 Multiple antibiotic resista... 146 7e-34 1 25.3% 1:217 14:222 MGELLSLGFVSFSAIFFVVDPFSAVPFFLAMTRRHSAEERRVIALRASIAAGVVLAGFALAGAWVFKLLGISLGAFKIAGGVVLLLLALDMIRTQPSRTR----ITEGEVEAGADKEDIAIVPLAMPLLAGPGGIATAVVLMARARGGP----WWHALPVLVAIALTAAASYAILAGATRTEKVLGRTGLAILERAAGLLLVAIGIQFMLDGLSESF----
53 UniRef50_Q11TX7 Multiple antibiotic resista... 145 9e-34 1 34.9% 5:219 1:204 ----MDLIFATVAALLPIINPFSTAPMFLSLTQGDTKSYRNAQATQGVIYMLAILLVSLVGGSFIMNFFGLSMPGMRIAGGILVAGVGMKMLKPNDEI-----ETTEAETKEAENKKDISFTPLAMPSLSGPGSISVVIGMSSLAKNISDYCYIA------LGIIFVACVVLLVLRSSVGLVKVLGVNGLHAMTKIMGFLILCVGIQFIIHGTMDILTG--
54 UniRef50_A5WGW0 Multiple antibiotic resista... 145 1e-33 1 25.3% 4:220 1:212 ---MDTEIVKIILAFVVLINPFSALTLFLDSTRGYSMTDKRRFARISSLTVFITIAFFTVAGETLLKVLGISVGSFQIAGGVLVFLIAINMMNGEGNPVknQENVEVDDSFESIGSTAAAVVPLAIPMMVGPGGISTVIIYSAQ------VTGWQQKLAIIIAGLLISIFCYLALMAAGQLSRFLGDTGLNIISRIMGMLLAAVAIEILVNGIKTVFPGL-
55 UniRef50_Q2FNQ4 Multiple antibiotic resista... 145 1e-33 1 24.7% 2:220 3:214 -PDLISFSLFALSSILIVVNPLGALLVYNSITEFMDSKDKRKVAAYGCRIAGAVLIFFTLFGSSLLSLFGITISAFTVAGGVLLFGIGMEMVYARTSRAK----VTATEKYESIDAEDISSMPLAFPMISGPGTITTVIVLSQDTPIFSEPVEL---GIILGSVIVTILITYIVLISSEQITKRIGQREYRVVNRLMGIMLMAIAVQFIINGISQAFPML-
56 UniRef50_B1ZWU7 Multiple antibiotic resista... 145 1e-33 1 38.3% 4:217 7:209 ---FWELILGTVIALLPLINPLASAPTFLAITDGDTPERRNQQLRMACLYTVGILVSFLIGGTFIMGFFGLSIPGLRIAGGLLVAGIGSHMLMSPPKPATDDPV-----HAAARAKRDISFSPLAMPMMSGPGSIAATISFTSLARG------WIDYVAIILGIIIVTVITYVTLRISDRVVRVVGFNSMNALSQVMGFLILCIGIQFVVNGVTEIV----
57 UniRef50_Q8TW39 Integral membrane protein o... 145 1e-33 1 23.1% 8:219 11:202 -------VLKGVIELFVVVDPIGNVPALLAVTSELRPRDRVRVVHRAVAFAAVLILGFAVAGKATLDYLGISVEALMIAGGILLLRAAFGMVEGDPTGFR----------IEPGSHIDVAYVPLGTPLLAGPGAIVTVIVMLHRH----------GRLETILACLIVMLLTLVTFRAAERLARFLGRSGIRVLTRVMGVLLAAIGVQMVLDGVSAFVRG--
58 UniRef50_Q11II0 Multiple antibiotic resista... 144 1e-33 1 28.0% 2:219 8:216 -MPPYDAILNAFTTLLVTVDPPGLAPLFLALTAGMNRQERHQVAIRACLISLGVLVLFALAGSSILSVLGITIPAFRVAGGMLLFVIAFEMIF---ERRQQRHKRSAERAITRDMIHNIAAFPLAIPLTAGPGAISATLLLSGTASAPGAR------LVMVAILLVVILITYLVFVLAERIDRFLGETGRSILTRLLGLLLSALAVQFVADGARELIQN--
59 UniRef50_A5FN26 Multiple antibiotic resista... 144 2e-33 1 33.3% 4:219 22:228 ---FMDLFIYLFAALFSVLNPIGTVPIFVGLTQHDSQKERSRISLWTAINVGIILLVSYFIGQYVLTFFGISIDALRIAGGIVIVNSGFSLLSGKF---NKKRGINKKIENEVQQRNDIALTPLAIPMLAGPGSISLLIAFYQEHHQMEE------ILFSCLAILAIAVVIFVILKSAHYLARILGASGIVAISRIVGFIVISIGIQYIVSSIVNIIKG--
60 UniRef50_Q8DGX4 Tlr2188 protein n=1 Tax=The... 144 2e-33 1 28.2% 1:220 1:207 MQPLLTFLLGTIAALFPITDPIAAIPVFYALTAKQSRRQRLKQARQVAINVAAVLTVFFFMGKLILAFFGISLPVVRIAGGLIVGHTAWQMV-------TSQDRLTQQEHIEAADKVDISLTPMAIPLISGPGAIAMTISLSTRCHT------WLEYLGAWLGILLLSAMVYLFLILGEPLSRAWGITDRGALTRLLGFLILAIAVQFIADGSLALLQTL-
61 UniRef50_B5EBI8 Multiple antibiotic resista... 144 3e-33 1 21.5% 3:221 7:215 --THMEQLIVFVVQLFVIVDPLAAVPIFLAITVSHTKQERRSIARRGCSIGLLAIVFFLVAGPSLLRYFAINTSAVQISGGLLLFVIALELLYGNPTGTQT----SSKEERLAEKKEDVSVTPLAIPLLAGPGAIVTCLVFSSQASDA------LSVLILIGGAVIVFSAAYLLLHWADELARIFGELGMKVAVRIIGLILAFIAVQYVINGITALWPAVK
62 UniRef50_Q1IU42 Multiple antibiotic resista... 144 3e-33 1 25.8% 4:216 9:210 ---IVQFTLVALSSVFFLVDPFAIIPTFLVMTARHDPITRRRMAARACWTAFIVLTAFAFAGTAIFKIFGITLPAFEIAGGLILLLIGLDMMQAER-----PTQEGSPETAEGSVKDDVSITPLGIPMLAGPGAISTVMVLNGTAR------DWSTTIPVFAAIALTCFASYWILRGAERVSQKMGQTGIRVLMRIMGLLLMAIAIQFMINGLTNL-----
63 UniRef50_Q0A888 Multiple antibiotic resista... 144 3e-33 1 26.4% 1:220 1:212 MLVLLEYLIITFVAVFVIVNPLTTSFVFMALLPTASARRRRTIARRATVIATALFFLFATLGGLIFQIFGITLAAFRIAGGLILFGVAMAMI--RQTLPSEAETAEQARNDEGRITDDISVIPLAIPFISGPGAIATVMILTSEAPT------LYHLALVYLAVLSCTVTCYFAMIYSRHIVRFLGDTGKEILTKIFGLILAVLAIQFVINGVSDAVTGY-
64 UniRef50_Q1H467 Multiple antibiotic resista... 143 3e-33 1 31.8% 1:220 3:216 ILEALKYISIVVIGLLPIMNPLTTIPLYMALTQRMTPETRKLQARKACIYAFFILTTFLLLGNGIIALFGISMAGIRVAGGLIILILALRMIFSGLDSSSSVDSEPEEIKSAN---LDYSFSPLAMPSLAGPGSIAVVMSFGSQIPEGSH---LIGDPIVIAGIAITIGIAYLALSSATHIEKMLGEHGMQAVTKIMGFLLTCVAVQFLASGIRDFYIEF-
65 UniRef50_Q59071 UPF0056 membrane protein MJ... 143 4e-33 1 25.7% 4:217 2:204 ---DLQYFILAFSSIFSILNPFGAVPVFITLTESYPKKERDLVAKKTVIYALAILLAFALFGEWILKFFGISLDAFKIAGGILLLLISLDMVRGQQEAKIHR-----KEIEAAYEIDEIALMPLATPLLAGPGSITACMVAMAEASDIGD------KFLVILAILLSLGITYLTLLSAESVLDRIGRLGIRILTRMMGLILTAIAVQMIVNGIRGAL----
66 UniRef50_B2S4M5 Hypothetical integral membr... 142 6e-33 1 19.7% 2:219 80:277 -MSTWTHIWSTAFTLLFIIDPIGNIPVVLSVLRTVPAERHTRIIFRELLLGLVLMLSFLFCGKVFLSLFQLETGVMKMAGSVILFLVGIKMVFPDQ------------HALPSTTEEEPFIVPIATPMIAGPSAFTTLVIMGETKGTSR--------LATCAALLVAWTLACLIMISAPCLYRLLKEKGITALERITGILLLILSIQMCVEGARGIIAT--
67 UniRef50_O28169 UPF0056 membrane protein AF... 142 7e-33 1 25.5% 4:215 6:206 ---YLSFFFASFTTLFIIIDPPGNLPIFIALTERFSDEYREKISKRATIIAFLILFITMVTGGKILDYFGVSISSLKIAGGILLFISSVDILLGG-----TRREAYKRRAEESIDVDSIAVFPLALPLYTGPGAITAGIVLYSQAG------DVVMKLLVVLSAALVYSIVRLSHIYSAPIIRLLGRSGADIAARILAIFLAAIAVEFVFDGLAE------
68 UniRef50_D1JFE0 Membrane protein, MarC fami... 142 9e-33 1 26.8% 4:216 2:203 ---DYAYAVSVFIAIFAIVNPLGNIAFFTTLTQDYSKAEKKKVATKAIIAATATLIIFALVGRYIFVLFNITIPAFRIAGGLLLLMIAFSMLYGTTPGTKS----TEKEKQESVEKEMVGVIPLGIPMLAGPGAISTVMLYISHGN-------IWDALIVFISVFATMAVTYIFLANADRIFNRVGRVGSLAISRIMGLILATVAIQFLINGTHEI-----
69 UniRef50_B8GXJ6 MarC family integral membra... 141 1e-32 1 22.4% 2:220 1:218 -MTEANLAVNFFVALFALIDPIGNVPLFAAATLGAAAAGRRMVAVYIGLFMAAFLIFFYFTGVGLLEFFGISMPAFRIAGGIILFILGLDMVRDDFTTMFADAAEGIEDQSpaKQRFERLIVPFAMPLLIGPGSISTVIIYAAEAKDFGA----AGMGIGVAVIAAVSLVTVLTFWASPLVSKVLGRIGMSIVVRVLGLILCALAVQFVLVGVADATRGL-
70 UniRef50_C7JEW2 Multiple antibiotic resista... 141 2e-32 1 26.0% 2:216 16:230 -TSSISSFLLAFPALFSIVNPFGAALIFAQATAGRSQTEIMALARLVSFYSLCLIMASLWLGSMVLAFFGITVNALRVAGGLVVAVRAWDLLQSPEtaQKEKQALQGGRTVMAPNWADAAFFPLAMPFTVGPGTIAVAIALGSGCP--ADEPFWAYTIGTTLAGVCVVAIVWAAYSGADKLVSMLGVTGTRIVSRMAALVLLCIGVQILAAGVQGF-----
71 UniRef50_A4SSK7 Multiple antibiotic resista... 141 2e-32 1 41.9% 4:218 2:206 ---FFQVVFLALLALLPMVNPPTTATLLLGLSKGMSREHVRRQVNLAAIYLFFTLCITFFIGSSILDLFGISIPGLRLAGGLIIGFIGFRMLFPAPSQTN-----------GVDINQSIAFVPLTMPSMCGPGTMALVISGAAqaELPDEYNRLTIYGAMVTAFALMSLISWGVLKLADPVCKILGATGIDAMTRIMGFLLVCMGMQFCINGIKEVAQ---
72 UniRef50_Q3DS24 Integral membrane protein o... 141 2e-32 1 24.7% 4:185 1:168 ---MISKFILAFMAFFAIMNPISNLPAFMALVADDDQKISRRIAAKGVLLAFVIIVIFVLSGHLLFNLFGITLAALKISGGILVGIIGYKMINGIHSPT------NKNLEEHKDDPMNVAVSPLAMPLLAGPGTIATAMGLSS--------GGLSGKLITILAFAILCVIMYVILISANEITKFL------------------------------------
73 UniRef50_A0KDA2 Multiple antibiotic resista... 141 2e-32 1 23.8% 4:217 28:232 ---DLTFSIKVFAALFAIMNPIANIPVFLSLTEGAADGVRRKVALTAAIGVTVGCIVSAVAGGAILHVFGLTIDDFRLAGGLLVLLIALSMLHGAPSRQHAP---GADESADPAAADSVAIYPLTIPLLVGPGTIATMIVLGHGAVATGQEFAFALGLAAFLVLLAVSLL------SAPLIGHYLSPRVTAVTQRLMGMILAAIAMQMIVASLKAAF----
74 UniRef50_Q6L1H0 Multiple antibiotic resista... 141 2e-32 1 24.4% 2:218 1:208 -MNYAYLFISSLVTLFAIMNPIGAVPILIALTDGYTKDERNNVILKSVFTAAGMMLGFMLIGVYIFQVLRISIYDFEIAGGMLLFKVAFDMLQGRTSPTK----ITSTEKEESVEREAIGVAPLGTPLLAGPGTITTAIIF-----FNGNGNAIMTRFVVIMSVIILIILTYIILKFSIPIFARLGKTGSIVITRIMGLLLASIGVQLVASGIINVFH---
75 UniRef50_B2KEY3 Multiple antibiotic resista... 141 2e-32 1 26.4% 4:219 2:215 ---DFSFLIGAFVGTLSILNPIGNVPIFLEHVQTDSPKMQRAIALLLGLSIFALLIFFFFIGRSALNLFSITIPAFRIAGGILILLVGIRMMQGKseGIQAAPAAQQNVFEEATFRLSSIIVPVAMPLFVGPGTITTVILFSDNTKT------LLNTVGMVLVLAICSAIVTICLLSSRYIYKILGNNGMQIVVRFMGMILCAMAVQFMIDGFAQLLPG--
76 UniRef50_Q11V88 Putative uncharacterized pr... 141 2e-32 1 23.1% 1:221 1:209 MSIDWSFALVVFTGLFAIINPIGNAPIFISFVDHLDKHQQKAIALKSVTVGFIILAIFVVFGYALFNVFNISIQAFRITGGLLVLKVGFDMINSKPKDAATLVKNSEATDT------GFAISPLATPILVGPGTLSTAVSFVGVGNKIENSIIIICSSAIILTI------TYFVFISSTTLIAKIGKEALNVVTKIMGLLIASIGIQMIITSIEELIHNYK
77 UniRef50_Q26F85 Multiple antibiotic resista... 140 3e-32 1 25.5% 1:220 1:206 MDDLLTFAFTVFTGFFAIMNPISNMPIFLTITEGADKETKQRINLKAIIVAFIIVSTFVLLGNYIFELFGITIPAFKITGGILIFFVGFEMLQSKKSNIKRLKTVNYDE--------NIAISPLAIPILAGPGTIVTATNFVANTSSYAD------IAVVLLVFALMCLLNYIAFSLSDVIAKKIGDNVISVIGKLMGLIIAIIGTSMIISGLKLSFDVL-
78 UniRef50_B8F4B7 Multiple antibiotic resista... 139 5e-32 1 22.7% 4:219 1:203 ---MFDSLVVQFVVLWAVIDPIGSIPVYLAKTVGLSPEDRRKIARNAILIAAGILLFFLVLGQWLLDAMQIPLSAFQIAGGLVLLLFALTMIFG--------ESKPDQEIKMKSNLHELAVYPLAVPSIASPGAMMAVVLLTDNHRY-----SFGDQVITTGIMLSVLLITYILFLVANRIQHFIGHAGAAIISRVMGLILSAVAINNILLGLKDFITQ--
79 UniRef50_B6R883 Putative uncharacterized pr... 139 6e-32 1 23.7% 6:220 24:227 -----TALITYVAALFSMMNPIGNTGVFAGMTADRDAATARRIAWTCAGAIALTLLTVTWTGGILLKFFGITVHELRAAGGVIVLLIALSMLRSDNSHRQTPQ-----EAASAAEQNHIAVVPLAIPIVAGPGAIATAIVAAERHSGIW------AKIDLSIAAVGLALFTGFLFSVSKPIANKLGESGMGVVTRLMGMVLAAIAMGMLADGVKGMIPAL-
80 UniRef50_A4SWC9 Multiple antibiotic resista... 139 6e-32 1 29.0% 5:218 6:219 ----LASFVTVFAALFPVINPLGDGPIFLNMVQGCSEGVRNKLARSVSVNCFFMLLASMLIGPQLLLFFGISLPALKLAGGAVVIAMGWNLLNQK---SASDKGANESTGITDETSDGSAFFPLTMPLTVGPGSIATAIALVAAYQESSSFseLPAVIGTVAALFALSLTIYFIYRESSGIQRIFGVNGTNVLMRLFAFILLAIGVQIFLGGINGYLE---
81 UniRef50_C0DXR4 Putative uncharacterized pr... 139 8e-32 1 25.2% 4:221 1:211 ---MITHILYLFTGLIVLNNPLIALGYFVDKTAGFTLKEQRKTARLVSISAFICMVVAGVIGTPLLKVLGIGIPAFQIAGGILVFVIAMSMMGGEDNPVK-PNLNKEHSSLPPEKQFAFAVVPMATPIIVGPGGFSIVIIYSSHVGT------WQGALELLIACFMVGVTCYLILAGSARLSKILGNVGIKIINRVSGLLLAAIAVEIVLAGLRSLFPALK
82 UniRef50_C7RRV2 Multiple antibiotic resista... 139 9e-32 1 29.0% 1:221 1:211 MDPTLTLFISLFTTLLAIINPLEAIPVYLGLMENRPESEQRQVARRACFYATLLSFFFLIFGTLLLRVFEVPLSMVRVVGGVILTRVGFELFAPPPSGGLIPRSGGNDT--------DVAFVPLAMPIMFGPGAIATLISMASTIKQSAEE--LIYFLAASLAIIACLGTTYISLIYAKPILRKIGTQGIDAATRIVGFFVAAMGMGLIFNGAVEFLESYR
83 UniRef50_A9W5P7 Multiple antibiotic resista... 138 1e-31 1 27.8% 2:217 8:222 -ETVLTSFLLALSSLFSIVNPVGSALMFAQITSDRSQAERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAAFAWTMLTAPEAREARKHAEVEAEPEAGENLAEVAFFPLTLPFTTGPGTIAVAIALGANRPSEPGELAGFF-LGASLAALAIAGVIRLAYGSADRVVTLIGSVRARVLGRLSAFLLLCVGTQITVSGVSDVL----
84 UniRef50_B8ICA0 Multiple antibiotic resista... 138 1e-31 1 27.7% 1:220 4:229 IESALQSFLLALPALFSIINPLGGALIFAEVTGRRTHEERVLLARRIGIYAAAVMLVSLWLGATLLSFFGISLAALRIAGGLVVAAQAWRLlaRKAADAASAKTRDREVGVESGGLDEIAFFPLTLPFTTGPGTISVIIALAASRPEAGA-ARWGFLLGATLAVLVIAASVRIAYASADRVVKRIGHARARVLGRLSAFLLLCIGTQITLTGVSDVLEPL-
85 UniRef50_Q3SRM8 Multiple antibiotic resista... 138 2e-31 1 27.8% 6:217 4:206 -----DYALTTFATLMVVVDPIGLAPVFLSITQGLPKAARRGIGWRASAIAAAILVATALGGTWLLARLGIGLPAFRISGGLLLFVVAFEMVLGVRPAREAQQATQAAE----EHARNIAAFPLAIPMIAGPGAITATLLLAGRAADQP-----VQLIALIAIIIAVAAICGVTFALAGRVAGALGHTGNVVLSRLLGVVLAALAVQFVIDGIREAF----
86 UniRef50_Q2RH58 Multiple antibiotic resista... 137 2e-31 1 22.1% 4:220 1:208 ---MSVFFLHAVVSILAILNPIGNLPIFLSLVEGEATADQIATARRATLAAFGFLTLFVLLGNNILLFFGITLAAFRVAGSIILFSIGYKILQGRNI---HSRSLAPDIHEDIMARDDVAITPLATPILAGPGSITTVMLLVGS------EWRLRTILLTVAAIAVVTLGTYLIFRYATLITRHLGPMEMNIISRVMGLLLAVIAVQMGASGLLELFPGL-
87 UniRef50_Q0W3L9 Putative multiple antibioti... 136 4e-31 1 22.8% 6:220 10:210 -----TLFIHALVGVFVIVNPFGNIPIFISLTSKLTPAERRTAIIKSLLIATAILLVFALIGQAVFTLLNVTLPSLRIAGGLLLLAIAFDMLMGRS---------PASKIDESDEREAVAVTPMATPLLAGPGAMSTVMILMNEAATND-----LQKLSIFLAILLAMGAAFLILINSELLYSVIKKDGSRVLTKIMGIVLATIAIEMMVNGLLKAFPVL-
88 UniRef50_Q12Z49 UPF056-domain protein n=2 T... 136 5e-31 1 22.9% 2:219 1:208 -MDHVSYFINSFITLFVIVSPITGVITFITLTNGLSLREKNVIAKKSVTLAFIISMFFIFTGTIILDVLGISLDSLKVAGGLLLLTVAFDMMHAK----ISRQSITDKEINASYERDDIWIFPIAMPILAGPATITTAIILTETAE------VVQQKMLLILAAVITYSVAMVTFLFSRRIHKKMGYNGMLVLTRLFGLFLGAISVDMIASGVWGLYMS--
89 UniRef50_B8ELV6 Multiple antibiotic resista... 136 6e-31 1 26.1% 1:218 1:209 MTKEWALFLSTFATLLAIINPFEALPIFLMLLEGKDLSEHRRVAARATLYATLLLFFFLIFGSLIMQLFGVPLSMVRIVGGIILVKIGFELFSPSPNGGSIIPDASSKTA-------NFAFVPLALPIMCGPGAIATV--LGMQSEIKEAPEHIGRFAATSLAILCAMFVTYLCLAYAGKLVDKLGPMGIDATTRIVGFFVSAMGVGLVFNGVLQGLH---
90 UniRef50_B8GMF3 Multiple antibiotic resista... 136 6e-31 1 25.5% 4:211 1:199 ---MFETLLAAFVLLFIVVDPIGVAAIYAALVQGADRREQKRIARNGVLLATGILLTFMLLGNGLLAMLGISIPAFRVAGGVLLFILSLDMIFARQSG---LRATTLKEQREAVRSQDISVFPLAFPLIAGPGAMTTVLLMASSGHDALVLTGLMGVVLLVLALALIAL------WFAPVIVRGLGETGINVVNRMLGLILSALAVQFILD----------
91 UniRef50_B4E5W5 MarC family integral membra... 136 7e-31 1 20.6% 4:221 1:201 ---MEYTFLSATVLLVLITDPLGNIPLFISAMRDVPRERRVKLILREVGIAFMILLFFMVVGDRFLRMMSLTDLSLRLGGGIVLFLIALRMIFPHPDGALGSDPRAGGE---------PFIVPLAIPALAGPSALATVMLLTSQAPGK--------MFEWVGALTVTMIVCAITLVLAERIQAWLGERTVAAFERLMGLVLVAISVEMLLAGIRAFVHQLQ
92 UniRef50_Q0W501 Conserved integral membrane... 136 8e-31 1 23.1% 5:220 3:211 ----FELFVSAAISIFVMSDPFGNIPIFLSLTGGMNRPQRRRVITKASIAATVIIFIFAVVGQPAMNLLGISLNALSIAGGMLLLLIALDMLMSTGLHAKRTESTENTTH-EDEEADSIAITPMATPLIVGPGVMAATVVFMNRA------AGLMDQALVLSAVLIAMLGSWIVMVNSDLLYAILHRDGTRVLTKVMGIILAAIATEMMISGLLNAFPAL-
93 UniRef50_C5CP73 Multiple antibiotic resista... 135 8e-31 1 24.1% 2:221 1:214 -MSTSMDLIKPLVTLVAIVNPLAIVPFFIHYTQGYSDAQRRHTVRMSAFSAFVVIAVSALIGLQLLAFFGISIASFQVGGGLLLLMSSLSMLNAKPAESKTNVEELRATEVKASMGASIAVVPLTIPLLTGPATISTVVIYADKTQHLWELGLLVGYGVV------VALATALAFSLAQPIARVLGKTGINIMTRLMGLILAALAVEVMADGLGKLFPILQ
94 UniRef50_A6SZ91 Multiple antibiotic resista... 135 1e-30 1 29.9% 4:217 5:218 ---FFKAAILVPITMLPIINPFGNAPVFASLLGNVSRDVEKKLARQVALNCFFLLLGAMFIGSHVLMFFGISIPIVRISGGLLVAFTAWRLLNdgQDAIRTQVATAPMEAWSDEEFKVRSFYPISFPLTVGPGAIAASITLGASTPARLLDQVISLGSAAVGA-AMTAFVIWLCYNSANKMVKMLGRLGTMVMLRLSAFILLCIGVEIFWTGVVGLL----
95 UniRef50_A5FZ91 Multiple antibiotic resista... 135 1e-30 1 23.7% 4:218 5:210 ---FIADFLYAAVALFVIIDPVGTAIIFAALTTHDDAAKRRTIAKRASAISFLVLLVFGLAGEKLLRLLGIGIPALQIAGGALLFLSAKDMV----TAKGELRASSEERSAASESTEDISVFPLAIPLIAGPGGMTTMVLLHAKAGGQPGAVLANALALAAMIAATL-----VSMLGARRLARLMGATGASVVGRVLGILVAALAAQFIIEGTQAALH---
96 UniRef50_Q464W8 Multiple antibiotic resista... 135 1e-30 1 25.2% 5:218 6:209 ----IGFLIHVFTIIFVVVNPISGVVTFISLTSKMRDEEKNEIAKKSVILACVIALFFAIAGDIILNLFSISVDSLRIAGGILLFSIAFDMMHAK----ISKGRITEEEISHSQEREDIWIFPISLPLLTGPGTISTVIVLM------GGTGAIVQKIIILVSITLAFIICYYIFQFSRMIHKLIGYNGMLVFTRLMGLLLAALAVDLIVKGILNIYQ---
97 UniRef50_Q0AE03 Multiple antibiotic resista... 134 1e-30 1 30.9% 1:217 1:204 MINPMDQYIQAIVALLAIANPLSAVPVFLQAVDGLDRTQRRKSALLAAISVFTILFVAAVAGNWMLDIFGISISAFRCGGGLVILLMGLTMLQGRTSSVQQ-------ESLTHNERRSKIFVPIAMPLVAGPGAITTVITIA------LAEPYWKNLSVALTAIVVLTMVLWVVLLLSQGVQGLLSPLGQKILLRFFGLILVAIGVQFILAGAYEFF----
98 UniRef50_D0XZK3 Multiple antibiotic resista... 134 1e-30 1 24.7% 2:220 1:217 -MSIQYLALNFIVALFALINPIGNLPVFAAMTAGAKPKARRRIAVYIGVFIIGLLGIFYLSGLALLQVFGISLSAFRIAGGAILFLLGLDMARNDLNGGDEADELaaDHPSYARRLFERILVPFAIPILIGPGAISTVVIYASETRSMGMDAMAAGMIGICAAAAAVVAVLWAT----PFISRLLGRVGMTVTVRVLGLILCAMAVQFMIMGAADATHGF-
99 UniRef50_Q01Z86 Multiple antibiotic resista... 134 2e-30 1 26.7% 3:219 9:222 --ELTKTTLLIVGALFPIVNPIGNTPIFLSLTHGLSSQGRTVLARMIAINGLILILASIFIGTHILAFFGISLPVVQVGGGMVVIATGWTLL--RQPNDDGSGDSGARDECHEADYKRQAFYPLTLPLTVGPGSISVAITVGANRP-EGAEWRWPLIGGMLLGSALIAVSIYLSYRFAERLAQTLGDSAMNVMIRLSSFILLCIGVQILWNGLSALLRT--
100 UniRef50_B3EKF2 Multiple antibiotic resista... 134 2e-30 1 27.6% 1:221 1:210 MHELLSHTLVMVGGYFAIMNPLANTAIFTAVTAGMDDRGIKKTALSAVVTALCIVLCFILLGRIIFDFFGITLPALRVAGGIMVFFIGFDMMHGRTSAAHAPAGG----GASGTPGQNLGISPLGIPILAGPGTIAVSMSYSATGNG-------LDIAVNALVFSVMCLITYVFFLLGEKVEQKLGREGLKVITQIMGLILSVIGVQIGIEGIFGAISLFQ
101 UniRef50_B0UBD2 Multiple antibiotic resista... 134 2e-30 1 26.4% 5:220 11:253 ----LQSFLLALPALFSIVNPLGAALIFAEVTGGRSHGERALLARRIGLYAAAVMLISLWMGAALLSFFGITLAALRIAGGLVVAAQAWRLLAAPEEREARKAAQAepEGVAGAGLDEIAFFPLTLPFTTGPGTISVAIALGASRPESGAARYGF-LLGASLAALVIALSVHLAYASADRVVARIGPARARVLGRLSAFLLLCVGTQITLTGVVDVLAPL-
102 UniRef50_A5W9L0 Multiple antibiotic resista... 134 3e-30 1 21.0% 4:217 1:196 ---MLHELFSVYLKMLVLYSPFFVLSCFISLTRGHSSKERKQLAWKVAFAALVASVMLYLFGRAIFGIFGITADAFRIGAGSVLFISALGMAQGKPA------------VQADNVQQDVTIVPLTIPLTVGPGTIGALLVMGVSQPH------WDEKLLAIVSIALASFTVGLVLYLSHGIERILGDQGLQIVSRLMGLFVCALAAQIIFTGIKGYL----
103 UniRef50_Q164H0 MarC family integral membra... 133 4e-30 1 26.9% 1:216 1:203 MIVDTAFLITAFVTMFVVIDPIGLAPLFVALTHGMSDEARRRIALRATLIAVIILLAFATFGEALLTFIGISMPAFRVAGGVLLFLTALDMLF-------ERRTKRREDRSEEDDSDDPSVFPLAIPLIAGPGSIASVILLMGQRPG------LEGAVMVLGATGLVMLIVLAFFLISGPVGRALGKTGITVVTRLLGMLLAALSVQFVLDGLAAF-----
104 UniRef50_C6BVR8 Multiple antibiotic resista... 133 4e-30 1 22.7% 4:219 1:199 ---MLALFFQTYLKLFFVLTPFFAISAFLSLTQEMSPAERKKTAVKVTVAVIVSSVILYLYGRYIFDVFGITLDAFRIGAGAVLFLSALNMVNG-----------GGKKFDAGKDDDDIAVVPLAIPIVVGPGTIGALLVMGSGVQGYKD------MFLACCALVAAVLTVGILLFISSSLKRLLGKRGLNIMSRLTGLVVASIAAQIFFTGLRNFMLN--
105 UniRef50_Q21G51 MCP methyltransferase, CheR... 133 5e-30 1 20.1% 5:218 1:202 ----MIDYLAVFITFFAVIDPIGTVPVFIAVTREYDQKTKRRIALLATIVAACVLLFFVVIGEIILKALSIPLSAFQISGGIVLFLFALNMIFGDSKP-------EEEIKFLEDDHKDTAIFPLAVPSIASPGAMLAAVLLTENA-----IFSLFEQVQTVVMMLLVLVVVYILMLLSGFITRFIGTSGASVVSRVMGLILSAIATTNILTGINEYYQ---
106 UniRef50_A3JXR0 Multiple antibiotic resista... 132 6e-30 1 19.4% 1:216 1:204 MVLDWSALLREFITLFVVVDPIGTLPVFYFATARVPQELHWKFAVRAVLVAWVVLIAFLVAGQWLLEGLGLRFGSFQIAGGIILFLFALTMIFGES-------KAEHEIEEAAREHFSGAVFPLAMPSIASPGAMLAIVVLTDNHAH-----SVPDQLMTAGLLTIVLILTLLLLLLGAQLKRVLGSTGASVVSRVMGIILATVAVDAVLGGLDAV-----
107 UniRef50_Q2FRJ2 Multiple antibiotic resista... 132 6e-30 1 26.0% 1:219 1:216 MVSDVGYLVGAIGTFFAILDPFGNLPFFIAYTNTLSAPVRRKTALVLSAFIFVAMAVFLFSGQMVLSFFHISLPAFQIAGGIILFGVALSMMSGTHTITMNRVISDTGKEMLLEKNESiiIVPLGIPLYVGPGSIAAAILFGSNAPTETAFLGGLLVILLIVIFITILNL------SSDYIGKVLGNQGIEILVRLMGLVLAAIAVQLTLDGITGAITT--
108 UniRef50_A9HK24 Multiple antibiotic resista... 132 8e-30 1 27.7% 4:216 20:232 ---FSDTFLLAFPALFSIVNPIGASLIFTQVTAGRARAESLALARTVALYSAVLLIASIWIGSAILAFFGITIDSLRIAGGLVVAVRAWALLQAPEeaRKEQQALQGGRTVAVPRWTEMAFFPMTMPFTVGPGTISVAIALSAGRPASSGW--LVFYVALSLAAIVVAGTIWLAYAYAERLMALLGVTGARIVSRLAALILLCIGVQILSAGIKGL-----
109 UniRef50_Q0FG46 Multiple antibiotic transpo... 132 1e-29 1 25.8% 4:216 1:200 ---MFELFVTAFVMLFLVIDPIGLLPIFISLTLGNN-KNRLKIGLRACSVALGILLLFGLLGENLLSFIGIGMPAFKISGGLLLFLTAVEMLF-------SKRGQRREEQTEMDVHDDPSVFPLATPLIAGPGSMATMILL-----LDSDVSGVTSTLVVLSAMISVVFLTFIFFSLGGPFERLLGKTGINVITRLMGMLLAALSVQFVVDGLNGL-----
110 UniRef50_Q89AL9 UPF0056 membrane protein bb... 132 1e-29 1 26.5% 2:220 5:214 -MFDFSIYISFFFSLFALVNPIGMIPIFTSMTNHQSIVERNKTNLIANFSVAIILSISLIFGSFILNLFGISINSFRISGGILVMIIAISMINGNFINNINNQKNG---KLDKDIARNISIVPLAMPLIAGPGAISSTIVWSTHY------SSVENIFGCMVTIMLFSCFCWTLFKVSPIIVDILGRTGINIMTRIMGLLLMSLGIEFILAGLKASCSNY-
111 UniRef50_A1SUP4 Multiple antibiotic resista... 131 1e-29 1 21.6% 4:216 2:196 ---DTTAYLHALTALFVIIDPIGAALIFNSLTGDCAKKHRTVMAVKAVLISGVTLILFGNYGEALFGHLGININSLRISGGLLLFYTAFNMV------------TKATGIMSASNSDDISVYPMSIPMISGPGTLTLSILLFSHT------TELSGKLAVSSAIISILALTLVCMLVSKYLKKIIGKTGDEILKRFFGIILAALAIQFIYDGIKNI-----
112 UniRef50_C5BZ38 Multiple antibiotic resista... 131 1e-29 1 26.2% 4:217 6:203 ---DVTLFSTTFLTLFVIMDPPGTVPVFLALTSTMTAKQRARAALQAVYVAFGVIMAFTLFGQAILRFLHISVPALQASGG-----------LLLLLVALELLTGKAEEPQPSGRGVNVALVPLGTPLLAGPGAIVASMLAVQQGDG-----DVASWVAIIAAIVLVHVSLWIAMRFAGVIHRVLGEGGTTLVTRIAGLLLAAIAVQLIADAVRAFV----
113 UniRef50_A5GJB9 Uncharacterized conserved m... 131 2e-29 1 21.4% 7:221 2:204 ------SLLHTAVGIFTISNPIGNLPIYLSFTDGNRRKDR-AIARSSAVTFLVSLMLATWLGNDLLGFFGISRPAFQVAGGLIVVLIGLSMLRSEPSKVHHDPASIERDQDSAVK----GIVPLGIPLLAGPGTLTVVIA-------DPNAASMGGKLGISGVVLLLTVVVYVIFEAGEMLSSKISASALQVLTKIMGLLLTSIAVQMIFTGLRAGFPVLK
114 UniRef50_Q2SCP9 Multiple antibiotic transpo... 131 2e-29 1 24.2% 2:220 1:210 -MLEFHEYTKILIGLMAIVNPVNAVPIFVAFTSNVSGAERKKIGKSVVIAVGLILLISMLLGEYLLSFFGITINSFRVAGGILILLMAISMLHAKVSATVHTEEET---VEEEGHHHSVAIVPLAMPLLAGPGAISTVILYAHRGTDAAH------YALVGVAILILCLTLWLVFSMIPWFSSHLTKTRINIFTRIMGLILAAIAIEFIANGLKGLFPVL-
115 UniRef50_A1TTZ1 Multiple antibiotic resista... 131 2e-29 1 29.6% 4:216 9:219 ---FGKSFLFVIAALLPIVNPAATAPIFLGLTEGASPTTRALLARRIARNMFWLLLGAMLVGSYVLEFFGISLPIVRVGGGMIVAATAWRLLTATQATVDSRTELA--ESFTPDMARRQAFYPLTFPVSCGPGSIAAAITVGVSLADARLSMSLARMGGGVLALLSVAVLLYFAFRYAQQLLKPLGEAGSVIFLRLSAFILLCLGVQIVWDGVYEL-----
116 UniRef50_C9YF10 UPF0056 membrane protein bb... 130 3e-29 1 20.4% 4:219 19:214 ---MNYTFASATILLILITDPVGNIPIFANALKHVAPERRPKVILREILIAFTLLLTFMFVGESFLRVMNLSELSLQIGGGVILFLIALRMVFPPAATA------------ETEIKTEPLIVPLAIPAVAGPSALATVLLLVSQQPDRRMEW--------IGALCVTMLVSAVVLVSAERIQRIIGDRLVVAAERLMGLVLVSVAIEMMLRGIKTFVHQ--
117 UniRef50_A6UWA4 Multiple antibiotic resista... 130 4e-29 1 24.4% 15:219 18:212 --------------IFIIMNPIGLVPLFYIWTSESEKTEKIELLRKSAIAVMLTLLTFALFGGSIFKFFGITLDSFKVAGGILMLKIAWDMLHAQVSKTRHNLK----DDEEPISLEDIAVVPMAIPLLAGPGTITTSIILMEHSITTYD------TLIIMFSIILATLISVVILYLSDNIARILRVSGIKAIVRIMGLILAAISIEIISSGVFGLIKS--
118 UniRef50_Q2RRC7 Multiple antibiotic resista... 130 4e-29 1 24.8% 4:217 1:208 ---MIDSLLSQITTLLVLVDPLGLLAIFVGLTAGRPAAYRRQVAIKGTLLATFVLVAFAVAGGKFLHLLGIDISAFRIAGGLMLLVLAHEMIFAKRT-IRRNESAKAMDKEMGGETSDPSVFPLAIPLIAGPGAITAVLLFSRESDGTAIGLMW-----VIVAILAVTLPTLALLLTAGAVQRMLGETLTHTLDRLLGIILGALAVQFIISGAKEAL----
119 UniRef50_B5JIG7 Putative uncharacterized pr... 129 5e-29 1 23.4% 2:215 1:204 -MGLLEYTLLAFVTLFVIVEPISIAPIFLAMTAGNDRSARTRTAKIACVTMVTVLLLFAVVGMSLLEFFGISVAAFQTSGGILLLLI----ALDMLQAKESSRKITQEESDAGTAKEDIAITPLAVPLLAGPGAITTCIVLANQAE------AWDQRMALYGVIIFICGLTFLILKLADKGAAWMNPLFMRVITRLAGLLLAALAVQFIFNGLRD------
120 UniRef50_B6IU07 MarC integral membrane fami... 129 5e-29 1 22.2% 4:215 1:207 ---MTDLILATAVAFLVTIDPIGLGPVFAGLTAGMEHSVRRRMAVKGVLIGAGLLFVFALVGEGLLKALGIGVGAFRIAGGILLLLLAIEMVFARESGIRATPDERAEAQDKVMHDADISVFPLGIPLIAGPGAMTSVVLLMGRASG-----DLASQAVVLGVLAAVLALTLVVLLFAAEVSRFMGVTGINVVNRVLGILLAALACQFVIDGLIE------
121 UniRef50_B1L4D5 Multiple antibiotic resista... 129 5e-29 1 25.1% 5:219 3:202 ----IEEVGISAIQIFAILNPISVIPIFLSLTEGRDEGEVRRIVGVVSVAIFIMMSIFSLAGELILKLMGISVRGLKIGGGAILMVLAVDMLQGMPRTKS-------------VEEEELAIVPLSTPLLVGPGTMTTILLLSNKYSGTYGY--LCSSLILTLASALVTVASYLILRNSGKLRKVLGVNGLRGLGRFMAIIVAATAADMISSGILDFIKS--
122 UniRef50_C5BLR4 MarC family integral membra... 129 6e-29 1 23.4% 5:213 1:201 ----MEYFIVAFMTFFATIGPLDVAAVFAALTARYKPREARKMAVKGILISISILLLFALSGEWLLSQLGISLAALRAGGGILLLLIGIDMVFARTSGGTS---TTADEEEEAITREDISVFPLATPLIAGPGSMGASILLMANAEGHPWQQGAVLLALAAILLLTLVML-----LAAAQIQRILGVTGMHVITRVFGVLLTALAVQFIFDGV--------
123 UniRef50_D1JAD6 Conserved hypothetical memb... 129 8e-29 1 25.5% 5:220 8:216 ----LTFSIGAIIAILVISNPISTSAIFIALTERMSRKQKQDTIKKSLTYSAGILILFALTGLLLFRIFGFTIGAFRIAGGVLLFTTAVGMLNPKTSQ-----------EEATDVPDNIALIPLSIPFTAGPGTIVTVVVLMSemHSTDLFTGIVCALGVFIGIATCLGVTYVMLAKSDLIDGALKEGGRRVVTTLMGLIVMAIAIQFFINGIKDILPDF-
124 UniRef50_Q08WP7 Putative uncharacterized pr... 129 8e-29 1 26.0% 41:217 2:168 ----------------------------------------RRTALRACLVACGLLLFFAVFGGVIFQVFGVSLGAFRIAGGILLLITALDMLRARPTETRTSR----TEEQESAAKEDVALVPLAMPLLAGPGAIASAMVLMAKGGT------LLMTVPVLAAIVLTFVASYFILRASHLVQRALRQSGVAILERVMGLILAAIAVQFMADGAKDLL----
125 UniRef50_D1B0T6 Multiple antibiotic resista... 129 1e-28 1 23.2% 1:220 1:211 MTEFFNLLLQHTITMMAIVDPLGVSAIMLSLLPQSTTKEHikIARKATLTIIVAFFVVLISGNFLLNLFSIEIDSLKVMGGIILLFTAIKMVQG----SMESKNQTEEEREEAIKNDEFSVIPLGVPITFGPGIFATIIILRGHSEG------FISIAALIMAYLIVALSVYLAFKNSIYIRKYLGITGQKIVSRLMGLIVGAIAVQFIVGGVSVLVKHY-
126 UniRef50_A2BM88 Predicted transporter prote... 128 1e-28 1 23.8% 6:219 10:204 -----ETLVQSIVLLFIAIDPIGNAPLFYSLTARLDARLRVRIVKQSCIVATSILFVFALTGNTALSYFGLTLADFRIAGGIVLLIYGIAGILGWT---------EAEMIRHPEEVESIAIVPLATPLLAGPAAIATVLYVRAVHGLTY----------ALASVTVNTAITFLMLYHSQKLMNLLGKNGAIALSKIMAMLLAAIAVAMIRTGIQDILAT--
127 UniRef50_C6E1T4 Multiple antibiotic resista... 128 1e-28 1 20.2% 1:218 1:200 METYSEFFFTVWIRFFFLLTPFFVLSTFLAMTPELSASERRATALRVTLAVLIACFVLYSFGNTLFSLFGITLDSFRIGAGSLLFLSAVHMVQGDDS------------APPSEKRGAISVVPLAIPVTVGPGTTGALLVMGAEVQHNWQ------VFVGLAALAAAVLCVGILLVCASFIEHIVGKKGITILSKLTGLFVAALAAQIVFTGVRNFLQ---
128 UniRef50_B9NS57 Putative uncharacterized pr... 128 1e-28 1 23.7% 5:219 1:209 ----MNNLLEHFVTLWVVIDPIGTIPVFIAVTAGIAAGARRKTALLAALVSAGILLFFLIFGQLVIEALDIGLNSFQVAGGIILFLFALTMIFGESKQAVEQR-QAEEDADDQLHKTNPAIFPLAVPSLASPGAMLAIVVLTDN-----NRYSIADQSITALVMLAVIAIAFVLMLLAEPIIRLIGHSGAAIISRVMGMILASVAVNSVLSATIAIIKT--
129 UniRef50_Q31LF6 Multiple antibiotic resista... 128 1e-28 1 25.0% 5:220 3:214 ----WPLVLNFAVALFAVTNPLGNLPIFISYVGKEKPSVQRLLALFLVLTVFISQLVFLLSGTAILRFFGISLAAFRIAGGIILLLIGINMIQGDRTKANQKLagIKSAFRRAETVYQSFFIPLGIPIFVGPASISTAVLYGNLANN------LATNLGLIGAVIAICIVSWLTLSVASWFERILGDLGLEITSRLLGLMLAAIGVQFILNGLGEATIGF-
130 UniRef50_Q2SQZ5 Multiple antibiotic transpo... 128 2e-28 1 27.2% 8:220 3:196 -------IVSALTLLIVVMDPLGNIPLFLSILERVDVKRRKKVLFRELLIALAILLVFLFCGQYLLKIFSLSKESVGIAGAIVLFIIALRMIFP-----------AKREWLEDLPDGEPFIVPLAIPFVAGPSALATLILISTREPERMMDWSI--------VVLLAWSVTAVTLMSSTFLYKVLRKRGIIAIERLMGMLLIAVSVEMFLTGLQPILTKL-
131 UniRef50_C6XRN8 Multiple antibiotic resista... 128 2e-28 1 24.4% 4:216 2:201 ---DWGSLYRDLITLFVVIDPIGTIPIFIAVTAGMAPENRPKVALIGVLIAAIVLYTFLILGQLVFEALGLALGSFQIAGGIILFLFALQMIFG--------PSKPEEELNQAKSISQSAVFPLAMPSIASPGAIMTVIILTDNHGH-----SVLEQTATAGLLLGVLVFTFVLLLLANPILKLIGTSGASVISRVMGMILSTVAVDAILNGFAVL-----
132 UniRef50_UPI0001746B52 hypothetical protein VspiD_... 127 2e-28 1 25.7% 9:218 7:197 --------ISALVLLLIVLDPLGNVPVFSSLLRQVEPARRKRVILRECGIALVVLFLFLAFGGGFLKLVGLSQSSLGIAGSIILFMIALRMVF-----------ESTEKVFGGLPQGEPFIVPMAIPMLAGPSALATVILFTTREG--------ISTLGAVGAISIAMGVTCIVLLLGERIIRLVGERGLAAMERLMGLLLTAIAVEMFLRGVKEFMK---
133 UniRef50_Q3SH12 Multiple antibiotic resista... 127 3e-28 1 22.7% 18:220 20:213 -----------------IVDPVGVIPIFLMATHGFTLTQSRAAARIAALTVLGVLTIFAFAGETLLTFFGIRLAAFSVAGGLLLLLLALSMVEAHVS----PQRQTQDEAVEAEEKDSVGVVPLGVPLLAGPGAITHVIVAAGALEGHTLQRGLLLLPVGLV-----ALSVWLAFRAAPVIAKRLGKTGIHVVTRLMGLIIAAISIEMIARGLGELFPGL-
134 UniRef50_A5G1Y0 Multiple antibiotic resista... 127 3e-28 1 28.1% 4:220 2:216 ---DLAFAARFLGAFFAIMNPFVTLPIFLSMTADRTVAEQRSIALQIGTYSTVMCLVIAVAGNAIIGFFGISIDAFRVAGGLVLLGIAFSMLNGHPITAHERGDHEKSADSAADAAdgIAFYPLTFPLVVGPGTIATLIIYAGQARGVPE------YVAFGLITALLLAVLIVVLYFAASIGRLLSARMRVVMTRLMGMILAAIAVGMVTAGLKILLPGL-
135 UniRef50_C1DWJ6 Putative membrane protein n... 127 4e-28 1 25.0% 2:221 1:211 -MDVLYLILKYTISIFAIVDPFGAIPLIISVLKNFSDKEREFIIKKASIYGCFILIFFLFLGNFFVGILGVSIADFQIAGGIILLLISINIIFGQPL----KEKISPEEIPLIKKLENIALIPVATPILAGPGAMVTAMTVASSQE------SLLNLLIVAISIVITFLISYFILKASKYIQKLLGEIFLDIVSRMMGIVIMALAVQFIVKGIknFFPILH
136 UniRef50_A3YU86 Putative uncharacterized pr... 126 4e-28 1 24.7% 6:220 9:217 -----HFMVQFVTSMVALLNPLGDFALFLALTQGRSRAEQKSIGNQAAVAIGVIMLTSLWLGRAILGGIGISIGAFSIAGGIVLFGIGLGMLNSK-SGDSSKTESNQDNIDAGRMKTSPAVVPLAIPISAGPGVITALLVASHSNE-----AGIPGLLALSVASVVMAGMMAVVFWYAPALGRLMGPSGMQITTQIMGLIVTAIASQMVLNGLKSAAPMF-
137 UniRef50_A8HQV8 Putative uncharacterized pr... 126 5e-28 1 27.1% 1:218 1:205 MLEDYDLFITQFVTLYALLEPIGHLSLFLALTGEHSKADRLRLAILSPLFAFAVLSFFALAGQTLLNAMNVSILSFQIAGGIILFSFSLSMIFG--------EAKKPSGVPEEKNLISQAIYPLATPTIAGPGAILSVVLLADNNRG-----SLIAQSMTVLAVASMMLLLMGAFLAGDIITRLIGSGGTNLVRRVMGILIAALSVDLVLSALAKWLH---
138 UniRef50_B2TBL8 Multiple antibiotic resista... 126 5e-28 1 25.9% 2:217 3:214 -ESLISDILFGFTGLISIINPIGIAFVFLDRTASLTTEERTALARKIAINVMCVLLVAFFIGTPILHFFGISMQALRIGGGLAVAVGGWQMLNAPDT---QPAEKPAVKRVDADNAMSKAFFPFTIPLTTGPGSIATAVALTANRTHKLSEFVISSIASVVISVT-VAVTVYLVYSRAVVFAKYLGVEGTKVAMRVSSFLLLCIGVQIMLTGFSEFL----
139 UniRef50_A1ANN4 Multiple antibiotic resista... 126 6e-28 1 19.8% 1:217 1:199 MQIYGSFFFGIWIKFFFLLTPFFVLSTFLSMTQRYEARERRKLALRVTVAVLVACFTLYFFGNTLFSLFGITLDSFRIGAGALLFLSAVQLVYGD------------DKAPPGGEREVISVVPLAIPITVGPGTTGALLVMGAEIQQSWE------ILVGCAALATAVLCIGLLLFCAASIEHLIGKRGIIILSKITGLFVAALAAQIVFTGIRNFM----
140 UniRef50_B5EQ08 Multiple antibiotic resista... 126 7e-28 1 19.4% 5:220 20:223 ----IEIFIQTLVTLLVLMDPIGIVPIFVSLTREQSTDQQKTTAKYISIVVALVLIISTLFGNDILRYFYIGIAEFNVSGGLLLLLMSIQMLTTDNISTTFGQGQASAYH------GGRLVTPLGIPFLAGPGAIGTVIIYGQHAHT------ILSYGLILIDVLIASFAAYIAMHNAHHISRFFGEIGIEIITKVAGLILGAIAVRFICQGLIRLLPGL-
141 UniRef50_A9NB13 Membrane protein, MarC fami... 126 7e-28 1 25.6% 7:217 2:192 ------TLYTIAITLILVMDPLGNIPVFLAILKQYDARTQVRIILRESIIAFFILALFVFFGRYILHGLHITTPALSIAGGVILFIIAIRMIFP------------PDQKPAKEDFEEPLIVPLAIPLTAGPSAMAMVLLFVTRDPHHLW--------LIFLGVFIASLIFTLIMLWAPYLIKILGKRGLTAIERLMGMILTTIAVQMFLAGIAEYL----
142 UniRef50_A3CST1 Multiple antibiotic resista... 125 1e-27 1 27.2% 4:220 10:206 ---FVGLTLVAVASITAVMNPASTTAVFTALTEGMTPDERRQVILTTVRISFIVLAFFALTGQLVFSIFNITVPAFQIAGGILLVTVATGML------------GSRGESYQAGDLENIAIVPLAFPLSCGPGTITAVILLTS--------AGASSLIAVFLGIAVALVISYVGMLYGPRIFAFIGEGGLRVVPKLMAVIVLAIAIQFIISGIAEAMPQL-
143 UniRef50_A8UZ22 Multiple antibiotic resista... 125 1e-27 1 17.9% 3:220 5:213 --DYLRTLLQFTIGLITILNPIAAAAIMVSltPPVSKRELVSISKKTTLTILTASLLSTFLGDLIFKLFDINIHSIKVIGGIILLLFSINMIKGKIFEASH----TPEEHEEAKEKDDISIIPLGIPILFGPGTFTTLVIFKTSTHN------WIDLFILITAIFISSVVVFLVFKNAVLLDKFLGITGVKITTRIMGLIVGAIASQFIVSGVKSLWDMY-
144 UniRef50_A4BBV6 Putative uncharacterized pr... 125 1e-27 1 22.4% 1:219 1:208 MVMNTTFFFNALTSYFVVIDPIGCALIFYSLTLGQSTRQKAKTILKSMAIALGIILSFAIAGERLLTALGISMDALRVAGGILLFNTAFRMITKVPEDQSL-----HHESPHDVRIGHITVYPLAIPLMAGPGTLTLTVLLMANGEQTVDQVMVIVAAVIVLLVTVLLS------VLSGKLRKVLGQTGDEIIQRLLGVLLAALAIQFVANGVNGLFLS--
145 UniRef50_C4XI48 MarC family integral membra... 124 2e-27 1 26.0% 7:221 4:206 ------TFQHYLLGLFAVANNIPALPLFMNLCRGAQTPVQHRLCGVATASSLATMAISLFIGAAVLDFFGISIAAFRIAGGLLLVSSGLSML------KSSCDEADGLPPVSVSRMIPMAVVPIAIPLTTGAGTISTIVLFAESAHT------MAGLLRIGGAICVMSVVNYLAFYYSPAIVRFLGRTGMDIFTKIFGLITLALGIQFIITGLTAAFPVLH
146 UniRef50_D1RJ36 MarC family integral membra... 124 3e-27 1 26.1% 1:218 1:221 MMVLIQAIFFSFAALFPIVNPVGASIVFLTLVKGSSRQQINALAIKISIYTVVMLLLVLVVGSLILSIFGITVPIVLISGGLLLTQVGWQMlhDESTGLSSSASQGKKISQLKSIEDPRAFYPLTLPVTAGPTCIAITIALGAHGAQNVWESKFLAMLGYSIGIILIGLSVFFCYRYSYYIFDKLKDAGKNVVMSLAAFLNICIGLQIIWRGIEMLIP---
147 UniRef50_C7R1Q1 Multiple antibiotic resista... 124 3e-27 1 25.1% 4:218 6:205 ---DIRLLIEVYVTLFVIMDPPGTVPIFLGLTGSMTAKQRAGAARTAIAVAAGVILAFAAFGQQLLTYMHISLPALQASGGL---------LLLLIAMQLLTGKMEEEADSPSNKNVNVALVPLGTPLLAGPGAIVASMLFVQRADASADW------FALAVGFAAICLTLWVSMRFAGVIHRLLGESGTILVTRIAGLLLAAIAVQLIADAVIAFVR---
148 UniRef50_Q89AB7 UPF0056 membrane protein bb... 123 4e-27 1 21.1% 5:217 1:197 ----MKEIISVTILLILIMDPLGNLPIFMSILKHLEPQRRKKILIREMMIALLIMLLFLFAGEKILIFLNLRAETVSVSGGIILFLIAIKMIFPTYESKKKSGNIIKRE--------EPFLVPLAIPLVAGPSLLATLMLLSHQYPKK--------ILYLIGSLLIAWMITVVILLLSDIFLRLFGSKGVNALERLMGLILIMLSTQMFLDGIKSWF----
149 UniRef50_B5HXX6 Integral membrane protein n... 123 4e-27 1 24.8% 2:219 1:200 -MFDVAVFGSLFLTLFVIMDPPGITPIFLALTAGRPGKVQKRMAFQAVCVAGGVIAVFGVLGHQILDYLHVSVPALMIA------------GGLLLLLIALDLLTGKTDEPKQTKDVNVALVPLGMPLLAGPGAIVSVILAVQKAH------SVATQVSVWTAILAIHVVLWLVMRYSLLIIRVIKDGGVVLVTRLAGMMLSAIAVQQIINGITQVIQG--
150 UniRef50_B9M3N7 Multiple antibiotic resista... 123 5e-27 1 24.9% 7:219 2:195 ------TFYAAVILLLLVMDPLGGIPFFISALKNVPEHRKKKVILRELLIALALMILFMFQGTKILKMLSISGPSLTIAGGIILLLIAIKMIFP-----------SKDEFMENVVGNEPLIVPLAIPYVSGPSALITVTLIMSREPHRWKEW--------LLALLFAWVVTGSILIMCTELERLLGERGVIAIERLMGMILTTIAVEMTLNGIVAFLAQ--
151 UniRef50_C3X219 Predicted protein n=2 Tax=O... 123 5e-27 1 19.4% 5:220 3:205 ----WGFLIKKTLTLLALVDPLMAIPLFICATAGLDTGFKDKYSRQLGITVALSLLIGGLFGLHLLDFMGVSLASIQIGGGAIMFIVSLAMVIAKEETIKYTPRETEEAAS------GPSIVPLGIPLLAGPAALSYVMATSQITQAE-------DLLSVILPPVVVGAATWLCFRFVGRGGRILTPSAIKVIERLAGFLLTAISVEMMATGFRHVFPGL-
152 UniRef50_Q4FNW7 MarC family protein n=2 Tax... 122 7e-27 1 24.2% 4:218 1:202 ---MLEIFIQTFFLYFIVIDPLGNTPLFLAVTQNMSSQQRVKTALSATIIASIILLFFAFLGSTLLNYLNISFPAFTIGGGIILLIISMEMLFDKRQQRK--------EDDIDFNSENVSVFPLATPIIAGPAAITSVIVSVSDMGSN-----FTNQSVGMIALASVLLLTFIFFFTASKFSQIINKKVISVISRVIAIILVGLSVQYILDGIKTFLA---
153 UniRef50_Q3JBV2 Multiple antibiotic resista... 122 7e-27 1 22.3% 5:219 11:257 ----WELLGNFFAALVGILNPVGKIAVWSELAGDLPPPVRFRLALWNCLIAAGLLLLFLWQGQSILSFFGIQLPAFKVGGGALLFITAVSLFEGKVKENFHLPQEGKSGPNPPSMPQSptIVPMAVPLLAGPGTLTIAILFGLRAEGRGEFLQLSGVLLLSLFFVLGLLSV------GPWLERRVGKPLLSALMRIFALLLAGIAAQLILEGLEPVISG--
154 UniRef50_B8D4C1 Multiple antibiotic resista... 122 8e-27 1 21.8% 2:217 1:197 -MDYLIILLSYFTQLIAIMNPFSAIPTFMSLTEGLERRRRLEIVKKAYFAGLILVILFTLVGRYILEAFNISIASLRVGGGIILMTIALDMLGDEVRTKRM-------------HPGDIAVVPIATPLIIGPGTITTILLLTSSLQET------TGMVVVLIAGVIACSVTFLILALSDILTRLLSMSTVRAIGRFMALIISGVAVEMIVQGLYSYY----
155 UniRef50_A7BE02 Putative uncharacterized pr... 122 1e-26 1 30.1% 1:216 1:203 MMTVLAGMSAAILALAPITNPIGGLAAFAGLTAGNAAAAVRSQAWKTGIYVFAILTVFAVSGSLIMRFFGFDLPSLQIAGGLVVSHSGFSML-------ENKRRATHEETQHATSKPDVSFSPMALPLIAGPGSIGVVIALAAR------NTAIGFHVGIVLGIAVTAAVIALLLRYGTPWIDKLGATGVGAIVRIMGFLILVIGVELIIHGVRAL-----
156 UniRef50_A3DKT0 Multiple antibiotic resista... 121 1e-26 1 25.3% 4:220 1:198 ---MFDLLFAYYIQLLAIMNPFSALPTFLSLTDHLDEIERKDIVRKAFITSIILVILFSLIGNYILLAFGISIASLRIGGGILLLVIALDMLGGMPRTKQ-------------IEYSDIAVVPLATPMVIGPGTITTILLLTSREPG------FLNIFLVLIASILAATTTFIMLRYSTKLVSILRVSVIRAIGRFMSLIIASVAVEMIALGIISFYHTY-
157 UniRef50_B0U0F2 Multiple antibiotic resista... 121 3e-26 1 27.2% 5:217 7:207 ----IAVILKFIISLFAIINPFSLAGIYLDTVKQSDQKEKNTIVFTMILAFLAILSLMVWFGNNILSIFGINQDAFRAGGGVIVLFFGLRILGVLAQPVS-------DTTVKIVSARDLAVVPLAIPLLAGPGTIATVITDSHEY-----FATIESKVIANLCLLFVAIVLWLFFRYLPKISAFLGEHTIDVISKIMGLMLVAISVEMIFDGIKGFF----
158 UniRef50_A8YHS2 Genome sequencing data, con... 120 4e-26 1 20.9% 5:195 3:192 ----WSFLRNFAITLFALLNPLGMLPIFISYTARERKEVQRLVALFVSLTVLCLLLIFMFIGTAMLKFFGVTLDSFRLAGGVLLLIIGINIVNGSGAGTKElnEQGGDYLSEAKSVYRQIVIPMAMPLLVGPGVIANVILYASEAESKLGRGT---SIELILMTILVSFLVFLILAAGKWLQRLLGDIGLSITQR--------------------------
159 UniRef50_A1VE68 Multiple antibiotic resista... 120 4e-26 1 19.9% 5:220 23:222 ----MQDAFEVALPLFLIMDPVGNAAASLAILREHTPSRQRAIIRRELVFALAIVLLFHFLGDALLGLLDIEQSTLRLSGGIILFIIAMKMVFP-----------PAQENDPEAVTRDPFIVPIAVPLIAGPSLLAAVMVYARQAQ-----AGMMGQASVLGGVLMAWGATALIMAFTPDLARILGPRAMRAMERLMGLILILMAVQMLENGIRIFVQSL-
160 UniRef50_D1N302 Multiple antibiotic resista... 120 4e-26 1 22.7% 2:217 1:201 -MMDVNMFIGMVVQFFFLLTPFFVLSLFVSLTSGMELPRQRKLAVRTTLAVMTIVLIIYLLGDRIFGYLGISLDAFRIGAGLVLLLSGIEVVRSSGTPSGTRQC---------DDDGDIAVVPLAIPYTVGPGTIGTLLTMGASADSARLRVTQ------IAGIVIAVLIMGLLLYFSAALERLLKKKGLNILSKLTGLFLAALASQLIFTGIRNIM----
161 UniRef50_A4X2W3 Multiple antibiotic resista... 119 5e-26 1 23.5% 4:220 2:200 ---DIKLFGEVFVTLLVIVDPPGMMPIFLALTGPLSARDRHRAAWQAVALALGVIAIFAVAGSTLLDYLHVDLPALQAA------------GGLLLVLVALELLTGKADDPSQQATSNIALVPLGTPLLAGPGAIVATMLFMQQADGAADITAIAGAIIA------VLLAVWVVLRFSGGIVKILRPGGIEVLTRIAGLLLAAIAVQLIADAVAAFVTQY-
162 UniRef50_C6QAI6 Multiple antibiotic resista... 119 6e-26 1 22.6% 4:215 1:204 ---MLETALKSLTTFFATIGPVEAAVLFATLTPKMPRAERQAIAIRATLIASAILAFFTVLGGPILAQLGVSVAALQTAGGIILLMIAIDMIFARPGGAI---KLTPPEGAEAQTREDVAVFPLATPLLAGPGAMSAGILLTANASDEP-----FGLAIVVASLACVMIATLALLLLAQELNRVMGITAQRVLIRVFGILLAALAVQALFNGIKD------
163 UniRef50_Q8K9B4 UPF0056 membrane protein BU... 119 7e-26 1 19.1% 5:219 1:196 ----MNEIISTTILLILIMDPLGNLPIFMTILKKLDAKRRRIVVIREMIIALIVMLIFLFVGEKILTILNLKTETVSISGGIILFLIAIKMIFPSDEGNNGTSSE-----------EEPFLVPLAIPLVAGPSLLATLMLLSHQYLHHMPY--------LVGSLLIAWFFTIIILLLSGLFLKLFGDKGVNALERLMGLILIMLSTQMFLDGIKAWFKN--
164 UniRef50_D1N0K9 Multiple antibiotic resista... 119 1e-25 1 20.5% 5:219 1:199 ----MDTFSSMLILFFLVMNPLGNLPVFIAELDRQPPERYRFIVLRECLIALAILLLFVFCGGEILKALRITQASLELAGGIILFMIAIKLVFGSASGSGEKKSAPESE---------PFIVPLAIPLFAGPAAMSTAILVGGR-------GGFMHTLEAAGALAAAWAICTAILLSGRYAGKFLGAKALSALESLMGLLLTTMAVEMIIAGIKYAFLS--
165 UniRef50_D1JAE0 Conserved hypothetical memb... 119 1e-25 1 19.4% 7:217 10:200 ------LLAKSFIMLFVVMDPPGNIPIFMALTKGMSGGERKKELNHAVVVATILLLLFAFLGTMILYVLGITPDSFMIAGGI-----------LLLLISFDLLRGEHKYGTSGDSGAGVGAVPLGTPLLAGPGAITAVMVLMQEEN---------GVFIALFAIFTAIIATRFLLGQAERIYSIIGKVGSEVLSRVIGILVAAIAIEFIAKGIAGMF----
166 UniRef50_A5EYD2 MarC family membrane protei... 118 1e-25 1 22.4% 7:211 2:191 ------SLTAAILTLFLIINPLGNVPVFLSILKNLSPKRQRIVLLRELCIAYAIMVVFLFGGSSILHGLNISREAVSISGAIVLFIIALRMIFPLRSGSVMGADDTEGE-------EEPLIVPIAIPFVAGPSLLATLIMMVESDPSLTTRW--------FFAMTISWFISLLIFLCAPFFFKILRKRGLKAVERLMGMILISISVQMMLN----------
167 UniRef50_A3DL90 Multiple antibiotic resista... 118 1e-25 1 22.1% 1:217 1:194 MEIDVYQLVSAILMLFVVLDAPGNAPLFYFFTKDMEPWKRIYTIRKSIIVAAFILLLFGLFGDYILLYFDITVNDFRIAGGIILFIYAVLGILGHTTA-------------EEVSGEEIAVVPLATPLLAGPGSITVVIYL----------KYSMGLLLTMLSIAINMIIAWILLENGGKLLQLLGKQGSTVLSKILAILLAAYSVAMIREGIISLI----
168 UniRef50_A6FM96 Multiple antibiotic resista... 118 1e-25 1 18.7% 1:214 1:202 MEKSLAHIMEEFAMLFAVVDPIGTIPVFLAIVISLPEEKRSSVAFKAVLIAGSLLLFFIAFGQMFLEAIGVSLSSFQLAGSLVLLLFGLNMIFGEARQDSEIGLAEKSDV-------ELAVYPLAIPSIASPGALLAVVLLTDNRTTP-----ILEQVITTGLVLVILMMTLACLLLATRVHKIIGNAGSSIISRVMGLIISALAVETGLDALS-------
169 UniRef50_B1Y4J7 Multiple antibiotic resista... 117 2e-25 1 20.3% 23:219 20:198 ----------------------GSIPIFISVLKGVAPERRTRVALREALIAFSVLAVFMVSGQHFLTLMRLSERSLEVAGG----------VILIIIAIRMIFSGGSEIYSQDGEPREPFIFPLAVPLLAGPSAMATVLLLASRQPDR--------LLDWAGALTAAMAICATVLLLAERIRKLLGDSMVSAIEKLMGLVLTAVAVEMILAGLKRYFLN--
170 UniRef50_Q31NH4 Multiple antibiotic resista... 117 3e-25 1 22.0% 11:219 9:216 ----------FATTLFAMLNPLGMLPVFISYTESERRQVQRWAALFISLTVFALLILFLLTGSTLLRFFGISLSSFRIAGGILLLLLGINLTIDNTAKQTRAIVKHEQESsaAESVYKKIVIPLAVPLLVGPGAIANVILHGTLAETEQQYGLLAEFALI---IALISLLTFIIFQSGRWFQKVIGDVGLSILTRILGLLVAAIGIQFLVAGVADVAAT--
171 UniRef50_A1SV44 Multiple antibiotic resista... 117 3e-25 1 27.4% 4:215 1:204 ---MIETAGLALATFFATIGPLDVAAVFAALTANQTDQQKRTVAIRGTLIGTAILVAFALVGELLLSSLGISLAALRAAGGILLLLIGIDMVFARSSGGTS---TTDDEEKEAISKTDISVFPLATPLIAGPGAMGSAILLMANQHG-----DLTGQVIIIFSLLAILFLTFISLLLASKLQNLLGITGMHVITRVMGVLLTALAVQFIFDGIKQ------
172 UniRef50_A2A0C4 Membrane protein, putative ... 117 4e-25 1 22.1% 5:221 1:204 ----MSELINSFLFLVAVLDPIGSVPVYLEATKDFDKKHKKKIAVRASFIAFMILLAFIVIGQFFLEGMSITLDAFRISGGLILFLFSLTMIFG--------ESKPESEKQLITDYKHVTIFPIAIPSIASPGAIMSVVILTDNH-----IYTIEQQIVTTLLVALVVFLTALILLAAVAVQKRIGDYGIIIISKVMGLILASYAVQNILSGLKNFFMSVK
173 UniRef50_Q6MDE2 Putative uncharacterized pr... 116 4e-25 1 20.8% 8:219 3:194 -------IFNIALVLFFIMDPIGNISSYQTMVKELDRRHQSKIIFREMLIALVAMIFFNYIGEFIFDFLDLSETTVRLSSGIILFLIAIKILF-----------TANDSPRANLPQGEPFIFPLAIPLIAGPGLMATIMLYAHLEPYQS---------IMLASILIAWTLSVIILYFSKKIKSFLGESGLMASERMIGMVLVLIAVQRFLEGILLFWTT--
174 UniRef50_A8ZZM6 Multiple antibiotic resista... 116 5e-25 1 21.0% 4:217 1:196 ---MTHLFLSLWIKLFFVFTPFFGLSMFLSLTEGYDEPRRRRVALTVSLAVAVLCLLLFFGGRQIFSLFGITLDAFRIGAGALLFLSGVGLVQGKPVNAG------------VASGSELAVVPLAMPIIVGPATIGILMVMGAELEGVRE------KMAGCMALLAAVACITVVLLMGSFIYRRLGAMGIGILSRLTGLVLAALSAQMIMTGIQAFL----
175 UniRef50_Q5UEW8 Membrane protein, putative ... 116 6e-25 1 21.1% 4:216 1:204 ---MVTELVSLALIYFAVIDPIGTIPIFLSITERFDYKQKQRVALRGCAIAFFVLVFFGFFGDLILSHLKISSATFNIAGGAILFLISMEMVNGRRQARKSQAVEKNR--VSAEELIRISSSPLGVPLLAGPGAITSIMVFG-------DFTSLDKLVINLSSIFIALAASALLLYLAAWGSKFINLTISTVMSRLVGILLAAIAIQIILNGLNKL-----
176 UniRef50_B1ZVN7 Multiple antibiotic resista... 116 7e-25 1 23.4% 1:214 1:192 MREFAGQFLQAFIPLFVAIDPIGLAAIFLALGTGVPLEQRRRIARQAAWTGGGVALLFLLLGQTIFGALGITASDFQIAGGLILFIIAARDIM------------HSAAEAPAKLADDFGVVPLGMPLIAGPASITTLILLAQT----------VGVWISLAALAVNLVLIVLAFAYSDKLGRLIGATGMRAISKIISLLLAAIAVNMIRQGVA-------
177 UniRef50_B2KBR5 Multiple antibiotic resista... 116 7e-25 1 21.5% 5:218 1:194 ----MEFIFSAVFTLLMVMDPFGNMPIFITALRKVSPERRRFILIRELCIALLIMLAFVFLGRQFLGMMGIKEYSLSIAGGLMLFIISLKLVFG-----------SSEDPGANPKDEEPFVVPLAIPLVAGPGSLSTIMILSAQSPSKS---------IIWMAVLIASALNLIILLFSFPISNLLGRRGLLALERLTGMLLVLLSVNMVMSGVADFMA---
178 UniRef50_D1R807 Putative uncharacterized pr... 116 7e-25 1 21.3% 6:221 4:199 -----QSIFSIALTLFLVTNPVGNAPAIIALIKDFDFSRQKAIMLREATFSLLLALFFQYFGEVFLNTLHIDRYTVSLCGGTLLFLISLSMIFPL-----------HHEETVKATKHEPFFVPIATPILSGPGLLAMIMLLSAQVSSN---------FAMSLAILLAWVGVFFVLLIAPYLNRVLGKRGLLALEQLMGLVLSIISTDMLVKGVEQFILSIR
179 UniRef50_A8A8R0 Multiple antibiotic resista... 116 7e-25 1 21.9% 4:218 2:193 ---DLNAVINAFISMLIIIDPFTNAPIFYQLTSSFEPKRRKRIIVRSATVSTIILLVFALFGDLIVRPFGMTLEDIKVATGLILLIYAIQALLGKS-------------EAEMIDPESVAIVPMAIPMLAGPGAISLVLYYRSVLEPYE----------LALVVVGVMLVSLPILLLGGYLDKLLGKNGTLALNRILAILMAGLGIAMVREGLLTFIR---
180 UniRef50_B1YA24 Multiple antibiotic resista... 115 9e-25 1 23.0% 3:215 6:196 --SDLMELLTAVVALYVIVDPLGNIPLFAALTAGLSEAQRSRVLLLSVLVASAVLVLFAVFGVEIFGYFGVELGDFMIASGLILISFSLH------------QLIRPYEQRPATDGLEVAVVPLAVPYLAGPASISYVLLMSKH----------MGVAPTLLAVAAVSLLTFATLRASGFIMRALGVLGIRVVEKIMLILSVAIGVSLVRRGLEA------
181 UniRef50_C2BT16 MarC family multiple antibi... 115 1e-24 1 21.5% 5:218 13:210 ----LGLFISTFTTLFVIIDPFGNLPVFMSLTKDLPKKQRQTVALQANLLAIVILFVFGFFGFQLFGLLGISPAALQISGG-----------LLLLIVALQLLTGAEGTVGEEGGSLNIAAVPLGTPLLAGPGSIVALMVAMGNAGHHP-----LSVIAVASGAFAVMFASWLAMHFATPIIHFLGNSGVAVMTRLAGMLLAAIAVELMISGVISVVQ---
182 UniRef50_A5FPP7 Multiple antibiotic resista... 115 1e-24 1 22.9% 1:214 1:191 MSDFWNNILLTFVPLFIVVDAVGNLPFVISITDQSTAEERKKVVNLAVITASLLGLLFLFMGKLVLDLMGISVGAFAIAGGLILLLFAIRYM-------------TSGHMVEVIKEEMVAVVPIGTPLTMGPATITTLILLVNQFP----------LYIVLISFALNMLATWLIFKSSQWFVHYMGRGGLKAMSRIFSLFLAAIAISMIIKGLR-------
183 UniRef50_D1R808 Putative uncharacterized pr... 115 1e-24 1 19.2% 7:220 5:198 ------SLFSITLVLFLIMDPLGNIGSFREMLKRIDPKKQKIIIMREMLIALFTMLVFNFLGEVIFEYLQVTETTVQISSGIILFLAALKILFP-----------SKDSPRSNLPQEEPFIIPLAIPLVAGPSLLATIMLYAHMETSVP---------LMLGSIFIAWGLASIILLFSNRLYTVLGNNGLVAFEKLMGMVLILLAIQRFLEGVENFVKTL-
184 UniRef50_Q4LEJ1 Integral membrane protein o... 114 2e-24 1 21.6% 6:218 7:195 -----DELIRASVSLFIVMDPIGLVPLIASLTSKLSIEQSRRVVRSTIYTASALLLAFAIAGHYILEAFGISLSSFRIAGG--------------LLLLLLSFELLLKGWELKGNEISIGAVPLAFPLLVGPGAITTILISLDRY----------GILVTMLSVAIVLALTMLTFSFMNTLNRLLGNLGSLIVSRVMAILIAGIAIEFILSGVEEFIA---
185 UniRef50_A1U7B4 Multiple antibiotic resista... 114 3e-24 1 24.3% 2:219 3:206 -ETFFSTYLSSTIRFLFLLAPFFVVTMFLALTRGLSMAEKTSIIRRACVSAFILGVILFFAGPLLFNAIGITLNSFRIGAGSLLFLTAISLVN--------SGTRNHATGLPEEDRDDIAVVPLAIPVMIGPATIGAIMVYGAELKAVPEVAGGLLGLVSGLMILA------GLLRLSGYLEKALGKTGLNIMSKISGLILSAMAAEIVLTGIAGFIAS--
186 UniRef50_B9KCI9 Integral membrane protein, ... 113 4e-24 1 20.1% 1:219 5:210 IESEIYIILLASVAIIAVLNPFGNLPQFIAMTEGLDADTRKKLFRNIIYTAFCIVLVFLLSGPFIMKyfKIDINDLRVAGGLILIIMSTKNLLFTPSSSQFQHYQG----LSHKELLKKSIVPMAFPMLVGPGTLSTVVVISEDQN----------LAIAIASVLLTFAFIFALFHFSATIEKVIGKLVLYVFSRIALVFIMAMGVKMIAIGVQTYIQS--
187 UniRef50_B5YIN6 Putative uncharacterized pr... 113 5e-24 1 19.0% 2:217 1:193 -MEILNTFLLTFIPLFVAIDAPGILPLYISLVEGVPDKERKHIARQSVITAFLVGTLFLFLGNFIFSLLGIKLEDFMIAGGILLLILSISDIL-------------RVKEKELTISDTLGVVPIGTPLLAGPATLTTLIILAGNY----------GYPIVIFSLSLNLLIAWVMLEKAEFVIKVMGIHGIKAFAKVMALLLSAIAVSLIKKGLTKIL----
188 UniRef50_A6VX13 Multiple antibiotic resista... 112 8e-24 1 18.5% 7:217 6:196 ------SILSATLLFLFVIDPFGNIPILLSVMKGVPQKRQYQIVVRDGLIGLVILVCFLFFGAEFLALLHLETESISIAGGVVLFVIALKMIFPSPYTK------------DAGPVMEPFIVPISIPMLAGPSTLATLLVMVKSYPNDQQN--------LLISVGAAWAISVAILAMAPLLNRILREKGLAALERLMGMLLLMMSVQMLVNGVRSLF----
189 UniRef50_B7VQK4 Multiple antibiotic resista... 112 9e-24 1 35.0% 1:217 7:213 LETLFTYMTLTVLGLLPIMNPPAAATVLLGLSKGRDKSYIVSQAKTTGVYLFIALCITFFIGASVLELFSISIPSLRLGGGIIIVAIGFNMLFPRPDNGAAPSGQ-----------DSIALVPLTIPSLCGPGSMAMIISLAAQIATYENHTSMTsyGGVVAGLALVALIATFTLTMAYPLLKALGQNGINAFTRIMGFLLICMGVQFFTLGIQEIV----
190 UniRef50_A1S0Q7 Multiple antibiotic resista... 111 2e-23 1 21.6% 9:216 13:198 --------LFVAVQLYAVLNPVSVIPTFVNLTEGLDSREKVHAVRKASMIVFSLMVVFSLIGDPLLRLLNVSIASLRLGGGVLLMVIAVDMLSGMSRTKG------------LESGDEALVVPIATPLLVGPGTITTLIVLSAS----------EGLPVTLLGALLATLLVYATLAFGESLLELLGRNFVRSLGRFMAIIIAGISAEMIHRALLEW-----
191 UniRef50_B2UQV9 Multiple antibiotic resista... 111 2e-23 1 19.3% 5:216 1:198 ----MQDFLSTVILLFIVIDPVGLAPMIQGMLKKYSPAQQKAILTRELVFALSLLLLFFFSGKFLLNLLGLEPSTLSISGGILLFLVALGMVFPAKDMLSSSGR--------ADGKDEPFIVPIAMPLMAGPSSLSIIMLHASQTPDS------ISQMTYAGAIVTAWFLSGMVLFIAQKFLRLLGEKGTIALERMMGMVLIMISVQMFMNGLAGY-----
192 UniRef50_C3WBK3 Integral membrane protein n... 111 3e-23 1 20.7% 5:217 8:206 ----VDAIFINALTLIAVLNPFGNVPLFIGMTEGMEKEIRNKLFKMIAITGFFITWIFSLFGEFLmnFYKINMNELKMAGGLILILMAIKNLIFSP-----QRKRTSEKQLSPDEQIKQAVIPMAFPMLVGPGSLTTALIGRSENGLTSN----------SFSILVAFIIIYLVLMVGNYLERIFGKLVLYILSKVMQIFIMSIGFRIFFDGLSHMI----
193 UniRef50_B2J6W5 Multiple antibiotic resista... 110 4e-23 1 23.1% 4:219 2:197 ---DISILVQTFIAVFVLADAVGNIPIVLVLTKGMMPDQRNKVIDKAIIVAIAVLLLFAFAGQVILNYLEISIGSLRVAGGV------------LLLLIALQMLRGELDQPIIEEGRDVAITPLALPLLAGPGTLTTVMLLMSKSQSPH--------IAVAVGILGAMFITWLILRLANLIDQWIGAEGGVIVTQLLGFLLAALAVEIGSTGIRELFLS--
194 UniRef50_A6Q130 Multiple antibiotic transpo... 109 7e-23 1 22.3% 4:218 5:213 ---FISILLHDIIALITIINPIAAASIMISMISPPTASAIADVARKATLTVFAASFVTLFGGEVVFQFFGINIYSIKIIGGIILMLIAINMAYGHGAKNRHSPEE----AQEAQEKEDIAIVPLGIPILFGPGVIATIVVLSHNNSSQLHPA--LSYILLSIAILIASLATYLTLRYASIINKALGVTGIKILTRIMGLIVGAIAAQFLISGIKGLWE---
195 UniRef50_A4XNM2 Multiple antibiotic resista... 109 8e-23 1 21.4% 8:217 3:193 -------IFSIAVLIFLVTDPFGNIAIYIAALKNVAPRRRLWIAARELLFALGLLLLFLTFGDKFLSSLGLSREATAIAGGIILFVIAMRLIFPSPQGL-----------LGDVPDGEPMLVPLATPAVAGPSALAVLMTLRNTHTGPLWE--------LYLAVILAWAATAFILLQASFLQRFLGNRGLMAVERLMGMLLIMLSVDMLLDNLQSVF----
196 UniRef50_Q9Y8Y7 Small neutral amino acid tr... 108 1e-22 1 20.2% 2:219 1:196 -MADLYTVVSSIILLFIVLDPVGVSPYVASIVARRPEGERERIVRTALASAGAILVAFTLIGVAVLDILGVSMDEFKVAAGLLLLIYATADLFEIKIGYSEP------------SGDEVAIFPLATPLLAGPGSIATVMYIMGS----------SGIAVALIAILVNLVLAYPILHASLKLVRLLGRHGSLLVAKFTAFLMVGFAVSIIFDGLRGIVPG--
197 UniRef50_A5ETX6 Putative multiple antibioti... 108 1e-22 1 19.5% 1:221 1:198 MPSTLEFVITTFVTFFVVIDPLGILPIFMALTGKKSVAIRQQIAVRAVLLAGPILIVFAFAGDTVFRFLGISLPAFRIAG--VPADYGLQ-----PRPKKTRQSKARTWRFFHLQYRS-----------AGPGAMTSVILIMGKAGS-----DFLIQLIAMSTLLSVLLLCLLVFLFASRLMAVLGLTGVNVIGRVFGIVLAGLAIQYMLDGFAAYIAILK
198 UniRef50_A7I7F8 Multiple antibiotic resista... 107 2e-22 1 23.3% 2:220 9:225 -MDQGTFFVTSLAALFAIINPVGNIPFFIMYTSEisPRTRQAVAVLLGPVIFVTVLLCMFFGSAVLSFFGVSMPAFEIAGAIILMIIALSMISGTRTEQVHAATSSETgwKAAEAYIPKIFIPLIFPIYIGGGTIAVSVLYGNDALTGG------FLAAAIGVTAIICIIIIACNLASDAITRVLGKQGLEIVARLVGVLLLGLAVQMFATGAGEMVATF-
199 UniRef50_A1SUW5 Multiple antibiotic resista... 107 2e-22 1 19.4% 4:219 1:199 ---MLETFFTLYLKMFFMMTPFFVLSIFLSLSKKLSNPAKKVVILRSSIAVAVAGLIFLLFGKYIFSLFGITLDAFKIGAGTVLFLSALEMIKGGEVPENTMKKGS-----------DFAIVPLAIPSAIGPGLIGVLMVIGAE------MSGVLGITLVILSLLAAVISLAGVLLLSNKLQDLIGEQGLEIIPKITGLFVSAIGAQIIFSGIQGFLLQ--
200 UniRef50_A1RZF3 Multiple antibiotic resista... 107 2e-22 1 19.7% 2:219 19:213 -VESLKELWDTFLMLFIVVDSIGNIPIFYSLTSGMGREERIKIFEKSVAVASALLVFFAVFGYPFFQYYGVSFTDFKI-------------AGGLLLLIIALQGVFGRVEAEALRSEDLAVVPMATPLLAGPGAIYMVMYLNS----------VYGLLPTLVSIALNTLASYLILTKSNVLLEKAGKNTILVLSRIFSLLLAVLAVSLIRSGIYEALRG--
201 UniRef50_Q89Z73 Multiple antibiotic resista... 107 3e-22 1 20.9% 13:218 15:220 ------------MALFPVINPLGNGFVVNGFFADLDPSQRKTAIQKLTINFIMIGVGTLLIGHLFLLIFGLAIPVIQLGGGILICKTAIELL-GDSNSSDKEGTSQNVDSFKWKSIEQKIFYPITFPISIGPGSISVIFTLMASASVKGKLltGINYLVIALVIICMAGILYVFLSQGQRIIQKLGPVGNQIINKLVAFFTFCIGIQISVTGISQIFH---
202 UniRef50_A7I5R8 Multiple antibiotic resista... 107 3e-22 1 18.9% 1:217 7:201 MTDIISGIIYAFAALFIILDPILSVPIFAGMTKGQSAREIHKQAFIAVAVAGILMYIFLVFNTAIFSVLGLTLSTFQIAGGILLFLLGMEMALGIDLCKSKEQVPTA------------AGVVIGTPLLCGPGAITTVMLLSNDY----------GILIPFIAISLSLAATWVILYYSAAIQNILGTVITDIMGRVLGMLVAGIAVKIIFSGIIGTL----
203 UniRef50_C6X1I7 Multiple antibiotic resista... 107 3e-22 1 15.3% 5:220 7:195 ----LKETLTATMVLFAVIDIVGSIPIIVSLKKRFGHIE----AGKATLAAMFLMIAFLFIGNKILKFIGVDVNSFAIAGAIVIFIIALEMILGIEIHKNQ-------------EAKSASIVPIAFPLIAGAGTLTTTLSLKAEYHD----------INIICGIILNTLFVYLVLKSANWIERKLGEGTLQVLQKVFGIVLLAISIKLFTANFAQLFSSY-
204 UniRef50_B9L924 Putative membrane protein n... 107 3e-22 1 20.9% 8:218 3:190 -------ILHIAVTLFLIMDPFGNFPVILSLLKDYNDKEKLQIIIRELIFAFVVIFIFIFFGKNIMNFLGLREESISIAGGIILFLIALKMIFPSSDPMFGKE-------------NELYLVPIAIPMIAGPSLLATLILFSSQYGISE----------VLGASLISWTLSALIIIISLKFSKIIPNRVFSAVEKLMGMLLISLSVQMLLDGIAKYLH---
205 UniRef50_A3ZTD8 Putative uncharacterized pr... 106 5e-22 1 22.2% 16:218 14:202 ---------------IATIDPIGTLSIFVGVTGKSPKEDRPRIALKATLIGGAVLLAFLVLGQFILGALDIRLESFQLAGGLILFLLGLQMVFG---------VGPAVEAPKAEAGHDVAVFPLALPSIASPGSILAVVILTDNHR-----FTMLEQAVTAVVLVVVLGLTYVLMLAANPIHRLIGDTGGMIIVKVMGLLLCALATENCVEAVQQLWS---
206 UniRef50_UPI000038253B COG2095: Multiple antibioti... 106 6e-22 1 27.7% 5:170 11:174 ----LTSFLLALSGLFSIVNPVGSALIFAQVTATRSQGERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAASAWTLLSAPETREARKHAEAAPESRE--NLAEIAFFPLTLPFTTGPGTIAVAIALGANRPSEPADLAAFFVGASLAALAIAGMV---------------------------------------------------
207 UniRef50_Q6L037 Multiple antibiotic resista... 105 8e-22 1 24.0% 13:216 1:184 ------------MPLLVVIDPFGSLAIFVSMTASYNKDTKLSISRDAVLYGGMILIIFAALGEIIIQFFGISIEALEIAGGIILLLMGIEMVREGAKPESSSGSK------------NLGIVPFATPLLAGPGAISLVIILM--------KGSLTTKIFTIVSILIVLALVYIFFIFSSKILEILGEKIMTAITRIFGLLLAGFAIQYFLDALISL-----
208 UniRef50_D0MK78 Multiple antibiotic resista... 105 1e-21 1 20.0% 5:219 1:197 ----MNAYLETFLPLFVAINLPGILPFFIALTEGLSAADRRRLLVRAVATAFVVAVLILFAGQLIFETLGITLNDLRVGGGLILLVLSITDLVFADYRRRDPRDGA--------DAADVGVVPLGIPLIIGPAAITTILVAQQTY----------GYLPTLVSLVANLLLVTAAFAAGPWVIRKLGPVAVRAIAKVASLFLAAIAVAMIRAGVAGMLAG--
209 UniRef50_Q2LRX6 MarC family integral membra... 105 1e-21 1 20.7% 5:217 1:192 ----MKSFWLCFVPLFVAVDAVGILPLFMSLTEGLETRKLRRIISQSVITAIAVALVFLVLGKALMDLLGITIADFMVAGGILLFVISLNDVLA-----------TEKAQQHTVDPDSLGAVPLGVPLISGPAVLTTTLLLSNSY----------GFVPTATALILNILLAGGVFFSSRIIYRFLGKTGAKTISKITSLLLAAIAVMIIRRGLFIIL----
210 UniRef50_A5GU87 Uncharacterized conserved m... 105 1e-21 1 24.5% 6:221 4:216 -----SSFQHYLIGLLAIGNNVSALGAFLLHTQGMPRAKVKRLILMSGLACLITLVLFMVVGTRILDFFGISVSAFQIAGGLLLGGVGLEMMnpLPTGAAASAAIPPAPDLSDAQFYSAAVVPIGIPLTIGAGTLSAVVLFAETAYRSGT------ALNLLGAILILVLVNTAIFRFSSRIMAWLGEVGVTIFIKLMGLFTLAIGVEFLTKGLGAIYLNLR
211 UniRef50_B7K783 Multiple antibiotic resista... 104 2e-21 1 15.8% 7:221 91:293 ------SAFNLFIIFFVTLGPIKIIPTFVRLTQKADKNFRCQLAFISATISTIVIVFVAIIGQNILKVWQIRLPALMITGGILLFLVALKIVM-------SQYNLSPKAESPENPSLDLAINPLVFPTILPPFGIAIALTFMVMSPQLG-----ISSVITLALLLLVMGLNLICMLAAHPILSFIKPVTLLILGFILGVMQLALGIEFILSGLEIEVLVLQ
212 UniRef50_Q6MDE1 Putative uncharacterized pr... 104 2e-21 1 16.8% 7:220 2:195 ------SVIQLAMIFFIVTNPIGNCPTIITLIKDYSIKQQQKILFRESIFSMILAILFLFLGEIFLTSFQIQNYALTISGGILLFIVALKMIFSDRLKTKTD-----------TPKQAPFIVPIATPLLSGAGLLTMIMLYSKEE---------ANDLKMLCAILLAWVGITTVLVTAPYLQIFLGKRGLAALEQLTGMLLAMIAIQMIVQGSGLFLTLL-
213 UniRef50_Q3A045 Multiple antibiotic transpo... 104 2e-21 1 20.7% 4:220 6:203 ---FFTLLLHDALLLLAVINPLGNIPVYRDLTSGMDFSKRRAMIQLGVGTAAAMIIGFALLGDWSlnLFEVTLDEFRIAGGILLFIVAVRGVM----------TGSLSYNLLSDDFRTRAIFPLAFPIIVGPGTLAVTIILAQNRPP----------LHMLAVSSVSCIIVYLIASSAHSLMRVIGGYAAMIIPRLLYIFLAAKAVALIMHGLTGYVQGL-
214 UniRef50_A5FMK4 Multiple antibiotic resista... 101 1e-20 1 20.7% 1:217 2:191 LEIDFKEIITVSMVLFAVIDIVGSIPIIVNLRAKVGHIE----SEKASIVAGAIMIVFLFVGEGLLNLIGIDVHSFAVAGSFVLFFLALEMILGIRIYR-------------DEEPGSASIVPLAFPLIAGAGTMTTLLSLRSQFHT----------INIITAIVLNIILVYIVLKSSKKIENLLGENGLGVVRKTFGVILLAIAVKLFAANVKGLF----
215 UniRef50_B8HLY6 Multiple antibiotic resista... 100 3e-20 1 19.5% 1:210 1:202 MPDTSPTLSYVFTIFFLTLGPVKTISAFFRLTREANPKFRQRVALQAALISTAICLFIAFIGHNVLAKWGVSLEALRLAGGLILLLFALKVVMMQPQPSAGVQVTADT---PLPDTLKLAITPLSTPVIVTPYGVVAILFYMVIAQGYA-----VLQVQILGIVFLIMLLNYLGMIFADKIMNIIGMPILQLIGWIFAVMQSALAIDIML-----------
216 UniRef50_C2M291 Putative membrane protein n... 99 1e-19 1 17.3% 5:218 3:189 ----LEHIAQISFKLFWIIDIIGGLPIFISLMNRFGKIQTEK----AALVSACLMIIFLFAGEAMLRFLDIPLKVFAVAGAFILFIIAVEMILGVSFHKM-------------EEANSISIVPIAFPLLAGPGVLTMILSLHSSY----------SSVDIVISILINVAIAYVVIKHCRRINDWMGQTGIVIANKIAGVILLALSIKMFADNWKTIFE---
217 UniRef50_O84860 UPF0056 membrane protein CT... 99 1e-19 1 18.2% 4:217 1:196 ---MLHSLFRLTLLFYALFNALGSLPVFIALLKNFSFKKQQHIILRESIFALLLLLLFVTFGRGFFRLLGIILPAFQFTGSLLLGSIAIDMMKALPPQTETLER----------DKDEPIFFPLAFPVITGPAMITSTLGHMEE--------GIFPKKIVLGAIVLAWLFSLITLLLSSSINRLFGQMGLLALERLFGISLALMAGNLMLKALSTAF----
218 UniRef50_C2M9S3 Multiple antibiotic resista... 99 1e-19 1 17.6% 5:220 17:207 ----LPSFFATFMILFVSIDIIGAIPIALSLKEKGKVFHPSKVA----IISAIMFMAFLFIGEPLLSFFGVDVSSFAVAGSIVLFVLAVEMIFGIQVFQDDDPSGNAD------------IVPLVFPLFAGAASFTAILTMRSSGTANST---------LFVAIILNVVCIYLMLRTVSLLERWLGKGGIYILRKFFGVVLLAISVKFFMQNLMIILEPF-
219 UniRef50_Q607N5 MarC family integral membra... 99 1e-19 1 18.0% 7:217 2:193 ------TLAQVAVLLFLITDPFGNLPLLLTVLQRLGHAAYLRAVLRETAIAFVVLVVFAWKGDLLLGYLNVTQPSLNIAGGVILTIISLKMIFGGAQETFDDRYANDPLVVPIAIPAIAGPAAL-----------TTVMLLSKQQGIPFPT--------LFTALTLVFLANLTTFLLGRLLGEWLGPRGLTALERLMGLLLNLVAVDMTMAGIKRFF----
220 UniRef50_C7LYJ4 Multiple antibiotic resista... 99 1e-19 1 29.4% 6:216 4:197 -----KFFVEALVTLLVIIDPIGNIPTFLVVTRGRDQRARRRLATEAVLVAAAVLAVFALAGSQILDYLGISIPALEVSGGLLLLIVALELLTGRGGSIGTT-----------EEGISVAVVPLATPLIAGPGAIAAVLVLAKRAATAP------LSVALAGALVGSMVILWVVLHYASALVRILKESGIALLSRVFGLLLAAIAVQLAAEGIRGF-----
221 UniRef50_D0SM32 MarC family integral membra... 98 3e-19 1 19.4% 4:219 1:203 ---MFSPYIHAFALFFSLLNPFLMSVYMIGMIRNTDAKVFSKALIQGCLIAFIVFILFAWGGESIfrYLNVRFESFQIFGGLIFLVIGYRYVFQGAETIGEMRGAPEHLAGT-----------IAMPFMIGPGTISAAVVTGISVPFSGAVAVIAITLMLTCSILILMKFAHDHLRyaKYIDRYF-----DIVGRLSALLIGTIAVDMIVNGIMGLIES--
222 UniRef50_UPI0001699175 multiple antibiotic resista... 97 4e-19 1 20.2% 7:179 8:169 ------EILSIAITLFLIMDPFGNIPVFLSILARVTEERRRVVLARELLLALVVILLFVFFGGTVMSLFGLSRAAVTIASGAILFLIALRLVFP-----------EKEAAADDEFEDEPLLVPLAVPLIAGPSLLAVLLVFTATEPDARGTLLIAALLAWLATSTILLASTFLYRVFSP------------------------------------------
223 UniRef50_Q4C088 Multiple antibiotic resista... 97 5e-19 1 14.3% 12:214 83:274 -----------TIILFMTIGPIKIIPVFARLTQNASKQVIIKLATRSFALSTLSILTVALASENILNKYIISLSSLIVAAGIVLFLISLKMLL------QQYDNQKNNPLPIPENPLTALISPLTFPTILTPQGIALVMISMTIAQRLDNNVDK-----ILGLIMVVMILNLLSMLDARQILTVLQPILLQILNLILSIIQLALAISFMFSGIT-------
224 UniRef50_C6HYD3 Multiple antibiotic resista... 95 1e-18 1 15.5% 5:217 1:196 ----MHTFWSVFLPLFVAIDPPGVLSIFFSLTQGVDIAQKRRTARSAVLTASLTVLFFDVFGTRLLDFLGLTLWDFT-------LAGGLLLLVLSVSDLLKNQDPETAGRPPGPFIGTLGPVPLGIPIIAGPATLTTSLIASKSASLAWALTALAA----------NMAILLAVLLAADRITRLLGAPLSAAVGKIFSLLLAAIAIHLIHRGIDGLL----
225 UniRef50_Q467G3 Multiple antibiotic resista... 95 2e-18 1 19.5% 55:218 1:154 ------------------------------------------------------MPFFAVTSNIILELFSISVDSLRVVGEILLFSIAFDMMHAK----ISRESITEEDISQSQEREDIWVFPIGLPLLIGPGEISTVIVLMGSTENIEHKIIILISIIFTF------ILCLYIFLLSRRIHKFIGYNGMLVFTKLMGLLLAALAVNLTSAGLKNIFS---
226 UniRef50_A1RTR6 Multiple antibiotic resista... 94 3e-18 1 19.2% 7:220 5:195 ------EFLGLVGQLYAIMNPIGKLAV-VGPLAVERPAYVRKITTVVIAVVYILAAIFAVSGGFILSAFGVSINSFRIAGGIVLMTISVTTLLSGSYVGR------------IEITEEHAVVPLATPLIVGPGTITALIVMSS----------IYGPLITLFIALTASTAVAITLIVGIRAVKYIGATPLRLVGRFMSLIIASVATEMILTGIRNYTQSL-
227 UniRef50_D2ASF4 Putative uncharacterized pr... 94 3e-18 1 19.6% 4:217 1:215 ---MSHPALILFLALFGLYSPVAALASYLPIVRPYSHGQVNRLALGLAFNVAVFVLAALWVGEPLLKLLGISTAALTATGGIALAYASIPLMRGKAGAVEELEKLQEQDkePAPDPKSILYTPLTFPLTVGGTTFAFGVAASASAAGTQD------KIALSIAALCFAAVTGLTLYLSGHVQRRISLKGAMLLDRVAGILLTAIAVILLANGFTDLV----
228 UniRef50_B1TBT7 Multiple antibiotic resista... 94 4e-18 1 20.0% 21:220 21:210 --------------------PPVAIPMYAAVTGHFPDATQRQIAFRLFAWIATLMVGAVWGGQFLLRMLGLTLGALTLTGGLVLCLWSIPMMRG----TANDERSGGDTRLEYAQWRNYIAVPLIFPLSIGSAVMSLVITTATRFHTP------VDLLALSAACILHAGVIGLTYACSASWCRRLGEIGRTLIERLSGIVLTAIAFQMLAQGVRELLPGL-
229 UniRef50_B3T2F3 Putative MarC family integr... 94 4e-18 1 26.4% 55:217 1:155 ------------------------------------------------------MITFAYAGRYLLDAIGVSLDSLKIAGGIILMILAIDILFEKRKTRREKRV---EEALDEKSFDDIIVFPIAIPFIAGPAALTTIILLIGNYTINTEF-----QIPVILALIAALVVSLILMIGANFIVKFLPKQILHATARVMAFILAALATQFIIDGIKASF----
230 UniRef50_D0ZDR8 Membrane efflux protein n=1... 94 4e-18 1 21.8% 1:220 1:211 METWLIHFLLTYVTFLSMFCPPATITAATILLGQTPPHTLRQLAWKVALEYVAVMLVAIWIGNYLLMALGLNAHALTATGGAALLFQGWPLM---TKGTKAEPARMVVTPDARPNVQDMVLVPLLFPLTIGGGTIAVGISLASH------DGSLAGLLQLSAVILLMAPTIALTFLAVGPLHGRLSSGAIDAMARIAGIVLVTLSLQLLASGLTQLVLQY-
231 UniRef50_A8Z5R7 MarC family integral membra... 93 5e-18 1 15.9% 13:219 1:182 ------------MVLFSIIDVIGNAPIIIGYKNKGDIINPNQV----TLVSLGIFLFFIFLGNFILNTFGIDIYTFSLAGSIILFFISLEMILGIEFYKRDKSTSAQ-----------VSIIPISFPLIAGPGSVTTLMSLKKNYDMQT----------ILISLILNMIIVFFVIKKIDYIENNISNDNLNIIKKVFGIILLSYSIKLFGRNICNIFNT--
232 UniRef50_B1WP37 Putative uncharacterized pr... 93 8e-18 1 14.9% 10:203 98:279 ---------NIFIIFFVTLGPIKIIPTFIKLTQNADDDLRKSLALNGAGLATIVIVLVVLIGGNILTRWTVSMSALLMAAGIMLFLASLQAVM-------SQYKGSAENEPLLEPSMKLLINPLTFPTILPPYGIALALILMVFNNRISDRP-----FIVPVMLILVMMLNLLAMLFARPILKTIKLPTLRIAGLVLGVMQLA------------------
233 UniRef50_A6T440 Multiple antibiotic transpo... 91 2e-17 1 16.1% 4:214 1:198 ---MEEAYLRSFALFFALFNPFLMSIYLLDLIRGLPTPTFARVLIRGSVISACVFVLFAWGGEAFfdYLQVRFASFQIFGGIVFLLIGLRYVFSGAAAIESLRDNPTAMAGS-----------IAMPIMIGPGTVSAAVVIGTRLPLGGAAVVIVGTLILTVSILVAMKVAHDKLK---ERHAAMTDRYIDLVGRMSALLIGTIAIDMILTGLQ-------
234 UniRef50_C9L1U4 MarC family integral membra... 91 2e-17 1 18.0% 5:221 22:212 ----WQQMVSAFIVLFAVI----DIIGSIPIIINLKERGKDVNAMKATVISFVLLIGFFYAGDMMLKLFHVDIESFAVAGAFVIFLMSLEMILDIEIFKNQGPIKEAT------------LVPLVFPLLAGAGAFTTLLSLRAEY----------ASVNIIIALVLNMIWVYFVVSMTGRVERFLGKGGIYIIRKFFGIILLAISVRLFTANITLLIEALH
235 UniRef50_B3ET88 Putative uncharacterized pr... 91 3e-17 1 19.2% 5:207 13:189 ----IKKFLTAFFILFAVIDVLGCTAIIINMRNKIGYIH----ARKTATVAGVIMVTFLFLGQTILDLFSIDMSSFIIAGSIILFLLGLEMCLNISIFKTDTDANSS------------SIVPLAFPIIAGTGTLSTLLILRAECET----------INVLLASLVNLVLIFLVLKYSEWIEAKLGRLGVSIIHKMMGIILIAIAIK--------------
236 UniRef50_D2PCH4 Multiple antibiotic resista... 91 4e-17 1 21.9% 2:216 1:199 -MSELVSIPEIAFKLYAIMDPLSILPYLIALYEEFNRNSQNKISwkLSIAVAVLLLFFSILGGPLLAFLGISVSALEIGGGIILVYLGVDTLGGFQQLKFLSSKI-----------EEAIITPIATPLIVGPGTMTGLITLSVSNNLIILILGSLLAALLVYLSLL----------LGPIIIRVLGNTGTVAVGRFMAIIIAAFGVQLIIDGISQI-----
237 UniRef50_C7LK11 MarC family integral membra... 89 8e-17 1 13.8% 2:219 5:197 -LQQIKLFFTCFLILFSIIDIIGNAPIII----GYKKKGNIINTKKITLVSMLIFLFFFFLGDFFLNSFGIDLYSFSLAGSIILFLVSLEMIFEIDFSKLEKKSN-----------IEISIIPISFPLIAGPGSVTTLMSLKTNYDIKT----------IMLSLILNMIFVFFVIKNIDFIEKKISKSNLYIIKKLFGIILLSFSIKVFGRNVCNIFPN--
238 UniRef50_A2SQL2 Multiple antibiotic resista... 89 1e-16 1 22.6% 42:218 3:168 -----------------------------------------RQAFVATGVAGVLMLTFLIFNNLLFDLLGIELESFKVAGGIILFILGLQIVLGLEIG-GSSAGHKSLESSDRIGKKSMAGVIIGTPVMCGPGTITTVMILGAQ----------DGIILTLVAVILALFCIWLILIFSAQIKKLLGETVLVILSKIVGLLLTAIAVHTIWTGILGLIA---
239 UniRef50_Q5WGH6 Putative uncharacterized pr... 87 4e-16 1 15.1% 4:221 1:193 ---MVSFFIHAFVSIFAILYPIGNLSVRLGLAHIKGDTQRIHKAAKAILVVLGALTTLLLLEQWLLLLYNISIEAFTIGCGLCLLVIGCKLLQGKTRYRSKQKTIFATVASQ--------------------GAAGATMCLTANQNHR-----WFYVPITFLAFVSVLVLSLLPLLVANWLRGRTGQKGLSLVKRATGVALTVIAIEMVVMGFADILPSFE
240 UniRef50_B5IJ45 Putative membrane efflux pr... 87 5e-16 1 18.7% 5:218 1:200 ----MEDLNRSVITLLALINPVICAVMLLERTPGVPHRRRLLLIGNVVLRTGLILLVSAAIGPQLLKRLGISLDVFQIVGGVVITSIGYGMFAPSPAPAAATGQESGSPENASLDPIVLFA--------ASPGTISTVLALSVMHGPDQGLLPTSLAVLIALAITAVVMAVMVLRPGAST------RSNSSLVSRFLGLILIAMGLQFVLTNLRTFFQ---
241 UniRef50_A6C262 Putative uncharacterized pr... 86 1e-15 1 16.5% 5:216 1:199 ----MNDVFNSTALLLTLLNPFLVIIYLVDVVQKLEQKQFRHVLMRAGLITSAIFCSFVVLGDKIfgVMQVEFASFQIFGGIVFLLIGIQFVFKGPVVIEALRGESSNISAS-----------IAMPVLIGPGTISACVLIGKRHEPLVACTIVVISVFVCLATILVLK---FIHDMVNQKRSALIDRYIEIMGRITALYVGTVSIDMIMQGLRTW-----
242 UniRef50_C5A3J5 Multiple antibiotic resista... 85 2e-15 1 19.9% 2:217 1:197 -MSEFSTILSSALLMLIMIDPSDKILLVSFLREDFHIEDIKALIVRANLIGFLLLASFAVAGQIIleIFHIDINALKVAGGFVLFKIGLEALEGGGMFTLKRER----------DILALAAVPVAMPLIAGPAAITAVITLTAEY----------GYLVSLSATAIAIAVVALSMFVALYMMKSVNKTFLSVTIRIIGLFIMAIGAQMMVEGVVGIY----
243 UniRef50_C6B1S6 Multiple antibiotic resista... 84 3e-15 1 17.2% 19:216 22:206 ------------------MGPKIALVPFLEKTHAFDTQTKVRIGRQMVMIAVVTALILFATGALLMRLLHITGGAVAVAGGIILALIAIKMASG-------PIEKPHDDIAAPVDPDKLAVFPLAVPYLLNPVGITVIIIASGE------VVSITSAILVIGLILIVGALDYLVFTNIDKLAKRMKPVTMIVSEVVFGILLTAVAVQLIVVGLGNL-----
244 UniRef50_D0SWE6 MarC family integral membra... 83 7e-15 1 15.8% 5:219 1:202 ----MSESLNAFALFFSLLNPFLMSIYMLGIIRNSDAKVFNMALIQGSLISFIVFIIFAKTGEAFFnvLHVRFESFQIFGGIIFLVIGYRYVFEGADTIGVMRGAPSHLAGT-----------IAMPFMIGPGTISASVITGIQLSLMQTILVIFSTLFLTCSLLILMK--YLHDHLQHKYSNYI-DLYVDIVGRVAALLIGTIAIDMIVTGVTGILET--
245 UniRef50_A8M8X4 Multiple antibiotic resista... 82 1e-14 1 17.6% 9:218 10:195 --------LVAAVQLYAIIDPLGAIPLLVSV--PDYEKMMNKFLRLVAVTVPLLLLLFAFAGPFIFYVFSININDFRVAGGIILLIIAIDVL------------REGTPKTMGINPEDYVIVPIITPMLVGPGAITSVMVMVTYYN----------IFSVITAVLIASLATYITMKYSVYLVKLIGNNTLKIFARFFSLIIASWAIQLIASGIINIVK---
246 UniRef50_B4B2T8 Multiple antibiotic resista... 79 8e-14 1 16.7% 8:216 4:201 -------LSSIFILLFITLGPLKTIIPFVELTAHSDEKLCRRVALRATFASTLVVLILGLLGPLILENWGVSLPAVSITGGIILFVGSLQVMMKPSESSGNKGVAPET------LSTSMLISRLVIPTIVTPPGIAAILALMVLSEKNQQLW-----LQIIGLLLLVMFLNLLIMLTARKLLAFLTVAGLRVIAWVFAVLQASLGAQVIINALRKL-----
247 UniRef50_O57953 UPF0056 membrane protein PH... 78 2e-13 1 19.4% 4:220 1:198 ---MLKEILSSALLMLIMIDPSDKILLVSLLREDFHIEDVKSLIIRANLIGFILLLLFAVAGKIIldIFHIELDALRVAGGFVLFKIGLEALEGGGMVTIKREK----------NILALAAVPVATPLIAGPAAITAAITLTAEH----------GIIVSIVGTLIAIAITAALMMIALYLMRGISKTALSVTIRIIGLFIMAIGAQMMITGAGGIVLNL-
248 UniRef50_B2S770 Multiple antibiotic resista... 76 6e-13 1 18.8% 2:219 1:204 -METGMIVGKLLPLLFNMMGPIGLMPIFAAMTVQMDKPTRNSVAARAAIFAALGILIAIFIGDPILRSWGISKPALILAAGVILTLSSIRAVLMPPAAPSQPAAAG--------DPKALAIRPLAFPTIVSPQGVGVLIIFVA------FLSSLSSTITILTVAGVIVLLDYGAMRIAHWFMATVGMVPLLVLGAVFGVLQVALGIEMMLSGLLLVLNS--
249 UniRef50_A8U398 Multiple antibiotic resista... 72 9e-12 1 22.1% 99:220 3:117 --------------------------------------------------------------------------------------------------RSEVDDATATATYGDAQAIKVGVVPLGIPLMAGPGSFTAVILESQHSHSG-------GSLSVSLTIIGVAAVMWVLYLLAVPIARILGPIGLNIITRLFGLVVTAIGVEIIVRGIQTHVASF-
250 UniRef50_D1BGR1 Cytochrome c biogenesis pro... 72 2e-11 1 18.5% 41:208 122:298 ----------------------------------------RRKSLRPYLVISGLVvfFTLLGSLILNALGLPQDLLRWVGLSLLAIIGVGMIVPRLEEIIERpaRQDRGAFLLGLGLGVLYVPCAGPVLA---AITVA---GATGNIGADTVALTVSFAVGAAIPLLIFALAG-RRVAERVGAFKRHtgIRIFGGVT-MILLAIGLAF-------------
251 UniRef50_B4V0W4 Integral membrane C-type cy... 67 4e-10 1 15.5% 47:220 166:342 ----------------------------------------------AVVAGLVVSffFTLLGVTIISALGLPQDILRYLGLGLLVMIGLGLILPPVerIPQRQVNKEGSAFVLGLGLGLLYVPCAGPVLA---AITVA---GARGEISSGIVALTLSFALGTAIPLLVFALAGRRVSARVAAFRTRARGLRIAAGTL-MIVLAFALAfaTTALQRALPNY-
252 UniRef50_Q0EYM7 Putative uncharacterized pr... 66 8e-10 1 17.8% 27:217 4:182 --------------------------YLLDLIQDLDRGTFFKVLFRATLISGSVFLVFAWGGDAIfdILQVQFSSFLIFGGIVIFIIALQMMFTGSDAIKKMRGGDPAHLSGS----------IAMPFMIGPGTISASVITGTTLSYPLALAAITLSLILTVLMLMVLKYAFDIIKV---RNADLLERYIDITGRASALLTGTIGVQMILQGIHKAL----
253 UniRef50_A7BB75 Putative uncharacterized pr... 62 2e-08 1 15.2% 42:206 80:245 -----------------------------------------SVTRRPVLIVLGLVTSFmvAGSALLSLLNLPQALIRWTGIVLLMAVGIGMIIPkpFTRLAPRTTGDSAGFGLGLVLGAAFVPCAGPVL------TSIIVASSSGQITWHIVGLAISFAIGVSIPLMIVAIAGSGVAARFLKTR--QRPLRIAAGV-AMIALALGI---------------
254 UniRef50_D0WLW3 Protein DipZ n=1 Tax=Actino... 61 3e-08 1 18.3% 4:172 2:178 ---FSQILIGLFGGLITGVSplPMLPifLAGATGASSDGkrKYPLLVTLGLVVSFTAVTLLGSTVLSLLGLPQDFIRWAGVAFLALIGVSLMIPKVerIRMKQVDKRSNGFVFGLVLGTAYVPCAGPVLA---AISVA---GSTGRVGAETAALAISFAVGVAVPLFFFALA-------------------------------------------------
255 UniRef50_P59960 Protein dipZ n=22 Tax=Actin... 61 4e-08 1 15.8% 38:220 162:353 -------------------------------------AVRRKRALSATlvIGGLVLSFglLGSALLSVLHLPQDAIRWAALVALVAIGAGLIFPrfSRIPQKQIVTRSNGFGLGLALGVLYVPCAGPILA------AIVVAGATATIGLGTVVLTATFALGAALPLLFFA-----LAGQRIAERVgqREIRIAT---GSVTILLAVALVFdaLQRAIPDY-
256 UniRef50_Q12GH3 Multiple antibiotic resista... 59 1e-07 1 18.5% 49:167 60:166 ------------------------------------------------VTARIVLLIFMVAGDRLLHAMRLTDASFEIAGGVILFLMAMGMAFPGMGVSLADSGHGG----------EPMLVPPAIPVITGPSALATVLLLAARQPDRG--WTWAAAIGLLLSAMAV------------------------------------------------------
257 UniRef50_Q92Z96 Putative uncharacterized pr... 57 3e-07 1 19.1% 55:216 7:151 ------------------------------------------------------LAIAGLLGRTMLENFEISLPVLAMTGGIILFLVALRTVLHQSSSLPDQTTEPGQPSDLR-----LALTPLAFP------TILAVIVFATLAGGRQAEGRT-----VAAIVLLILAMDWAAMIFAESILRWIG-TSLQVLAVVLGVTQAALGLQIILHSLSTV-----
258 UniRef50_A6FJM2 Putative uncharacterized pr... 52 2e-05 1 22.9% 1:70 1:70 MSQLFEHALTVFMAFFAIMNPIANTTVFAGLTGSMGKSEQVKIAVKSLTITFVIIVLFSILGKSIFHLFG-------------------------------------------------------------------------------------------------------------------------------------------------------
259 UniRef50_D1K837 MarC family integral membra... 51 4e-05 1 22.7% 50:115 9:74 -------------------------------------------------ISFITLLAFTFSGQFLFKFFSISTNNFRIAASFIILKIGYDMLQARFTNTKLKNKEIKTYANDIPS----------------------------------------------------------------------------------------------------------
260 UniRef50_C2CQB7 Integral membrane C family ... 46 7e-04 1 15.8% 1:171 1:173 MLSTLS--IGLVGGLVTGLSplPILPLVLAV-SGNGGRSRPWLVIGGLVTSFTAVTLFA---TTLLNALHLPGDLVWKVGIGLLVLVGLGMMFPKFQEILeqAKARDKGGFAVGLALGVVFVPCAGPVLA---AISVA---GATGTIDAHILILCLAFAVGVAIPLMAFAL--------------------------------------------------
261 UniRef50_A2V4T5 Putative uncharacterized pr... 45 0.002 1 48.7% 179:217 28:66 ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------KPICKFMGKTGIDALTRIMGFLLVSMGMQFMINAVKDLL----
262 UniRef50_Q8ZY52 Putative uncharacterized pr... 44 0.003 1 20.3% 7:80 5:77 ------EFLGLVGQLYAIMNPIGKLAI-VGPLAVEKPTYVRKITVVVIIAVYILSLIFALSGGLILAAFGVSLDSFRIAG---------------------------------------------------------------------------------------------------------------------------------------------
263 UniRef50_Q255K2 Multiple antibiotic resista... 43 0.006 1 13.9% 2:217 1:201 -MDTMYLLFPQACILLLAADALTNVLALNCVLSNYSRKKRLSLLIRESLFALVSMFALYAAALGTLYVLKTPPCAIQVVGGIAVTLAGMRAIL--------NLNRENTWQGFASTSSLSLVTPIALPLMIGPSWLAACCILIGKRYSFTSISLILFLSWALISLTTIILQVFIG-------VGKEKTKVLLATQTVLGLFATIVGTQLLMSGLQLAF----
264 UniRef50_B6R4W8 Phosphate transport system ... 41 0.026 1 14.7% 1:211 390:608 MAGIWGAAVGSFWTMLVTLspIGVAAAIY--LEEFAPKNRWTHLIEVNilAAVPSIVFGLLgaVFLNVFGLPRSA-PVVGGMVLALMTltIIIASRAALQAVPPSIREAALGVGASRLQAVfpLAMP-----GILTGTIIGMAQALGETAPLLMIGMVAFIVDIPasTVLPVQIFMWADFPEPAFQQKTSAAIMVLLGFLISMNAIAIVLR----------
265 UniRef50_A6G157 Putative exported cytochrom... 41 0.031 1 17.2% 4:119 205:332 ---LFQFLVGSFIalLALLTpfPMIPITISFFAKHAEASRKKSLIMAGTYSGAIVVCFTILGVGASVIFgiPFNIFMF---LLLFVFGLSllFEISAPRFLIEKSSEMEQKYSEDEEAP------------------------------------------------------------------------------------------------------
266 UniRef50_C4XRQ9 Thiol:disulfide interchange... 41 0.038 1 16.1% 29:202 403:577 ----------------------------LAISGEEGRQERRRILREHNFFFALGIVTYFLCLSLILGAFGmqSPSLAIVAAVVLFALALSlvFHLPVVDLKITSGGRGHTRRGAFLTGALATLLATPC-SGP--------FLGGVLAWTLLQPQHVIMTVFAAIGLGMASPYGVLAIWPRLVRLLPRPgmQSLERVMAFLLA-------------------
267 UniRef50_A6V064 Thiol:disulfide interchange... 40 0.048 1 10.2% 44:210 354:514 -------------------------------------------AVLVCLALGAVLMALRALGSEIGWAFQLQNPAVILL--LILLTSAMGllFELGSLSAGSRLAGQDGPAGAFWTGGLAAfpCSGPFMAG--ALGAALVL-----------PPLAGLLVFAGLGFGLALPFLLLSFAPVLQGWLPRPgmQTLRRVLAILLFASAVWLVW-----------
268 UniRef50_Q9VKA3 CG31860 n=3 Tax=Diptera Rep... 39 0.087 1 9.4% 42:212 303:473 -----------------------------------------KAARRVLIIACILCTIFlvIGGILSNSLAIATDAAHLLTDLASFLISISALHLAGRPSSERLNYGWHRAEVIGAMVSIFF----IWVVTG------ILVYMAIMRWVNQDFELDAKIMLITSALAILFNVIMAMQlsLPGVHKMSKDAGSVLGSKMILLLgsVSMQYAAKG---------
consensus/100% .............................................................................................................................................................................................................................
consensus/90% ..............hh.hhss...h.hhh.hh.t..........h...h..hhhhhh.hhhGt.hhthhtlt..shthsuuhhlh..uhthh............................h.PhshP.hhusushs.hh.h....................h.h.h..h..hh.h..s..h.thht..h..hh.ph.uhhh..huhthhh.sh.......
consensus/80% ......hh..hh.hh.hhsPhs.hshhhshhtt.s.ttp.thhhh..hhshhhhhhhhhhGt.lhthhslshsshpluGGlllhhhuhphl.........................t..hhPluhPhhsGPuslsshhhh.tt.............h.hhhshhhhhhh.hhhhh.u..l.phls..sh.hht+lhuhllhsluhphhhtGh.th....
consensus/70% ...h..hh.hhhhlhslhsPhushslahshstths.tpppphshpsslhshhlhhhhhhhGphllphhulolsuhpluGGlllhhhuhphl.s.......................phuhhPluhPhlsGPGslsshlhhtsph............hhhhhshhhhhhhshhhhhhuthl.chlGttuhtlls+lhGhllhslulphhhsGltthh...
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown